Company Quick10K Filing
Helen of Troy
Price138.29 EPS5
Shares25 P/E29
MCap3,491 P/FCF30
Net Debt303 EBIT149
TEV3,794 TEV/EBIT25
TTM 2019-05-31, in MM, except price, ratios
10-K 2020-02-29 Filed 2020-04-29
10-Q 2019-11-30 Filed 2020-01-09
10-Q 2019-08-31 Filed 2019-10-10
10-Q 2019-05-31 Filed 2019-07-10
10-K 2019-02-28 Filed 2019-04-29
10-Q 2018-11-30 Filed 2019-01-09
10-Q 2018-08-31 Filed 2018-10-10
10-Q 2018-05-31 Filed 2018-07-10
10-K 2018-02-28 Filed 2018-04-30
10-Q 2017-11-30 Filed 2018-01-09
10-Q 2017-08-31 Filed 2017-10-10
10-Q 2017-05-31 Filed 2017-07-10
10-K 2017-02-28 Filed 2017-05-01
10-Q 2016-11-30 Filed 2017-01-09
10-Q 2016-08-31 Filed 2016-10-11
10-Q 2016-05-31 Filed 2016-07-11
10-K 2016-02-29 Filed 2016-04-29
10-Q 2015-11-30 Filed 2016-01-11
10-Q 2015-08-31 Filed 2015-10-13
10-Q 2015-05-31 Filed 2015-07-10
10-K 2015-02-28 Filed 2015-04-29
10-Q 2014-11-30 Filed 2015-01-09
10-Q 2014-08-31 Filed 2014-10-10
10-Q 2014-05-31 Filed 2014-07-10
10-K 2014-02-28 Filed 2014-04-29
10-Q 2013-11-30 Filed 2014-01-09
10-Q 2013-08-31 Filed 2013-10-10
10-K 2013-02-28 Filed 2013-04-29
10-Q 2012-11-30 Filed 2013-01-09
10-Q 2012-08-31 Filed 2012-10-10
10-Q 2012-05-31 Filed 2012-07-10
10-K 2012-02-29 Filed 2012-04-30
10-Q 2011-11-30 Filed 2012-01-06
10-Q 2011-08-31 Filed 2011-10-07
10-Q 2011-05-31 Filed 2011-07-11
10-K 2011-02-28 Filed 2011-05-16
10-Q 2010-11-30 Filed 2011-01-10
10-Q 2010-08-31 Filed 2010-10-06
10-Q 2010-05-31 Filed 2010-07-09
10-K 2010-02-28 Filed 2010-05-13
10-Q 2009-11-30 Filed 2010-01-11
8-K 2020-05-14 Enter Agreement, Exhibits
8-K 2020-05-04 Earnings, Exhibits
8-K 2020-04-28 Officers
8-K 2020-03-30 Off-BS Arrangement, Officers, Regulation FD
8-K 2020-03-17 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2020-01-28 Other Events
8-K 2020-01-23 M&A, Off-BS Arrangement, Regulation FD, Exhibits
8-K 2020-01-08 Earnings, Exhibits
8-K 2019-12-19 Regulation FD, Other Events, Exhibits
8-K 2019-10-08 Earnings, Exhibits
8-K 2019-08-23 Shareholder Vote
8-K 2019-07-09 Earnings, Exhibits
8-K 2019-06-21 Officers, Exhibits
8-K 2019-05-21 Regulation FD, Exhibits
8-K 2019-04-26 Earnings, Exhibits
8-K 2019-01-08 Earnings, Exhibits
8-K 2018-11-07 Exhibits
8-K 2018-10-09 Earnings, Exhibits
8-K 2018-08-22 Officers, Shareholder Vote, Exhibits
8-K 2018-07-09 Earnings, Exhibits
8-K 2018-04-26 Earnings, Exhibits
8-K 2018-03-01 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2018-01-24 Officers
8-K 2018-01-08 Earnings, Exhibits

HELE 10K Annual Report

Part I
Item 1. Business
Item 1A. Risk Factors
Item 1B. Unresolved Staff Comments
Item 2. Properties
Item 3. Legal Proceedings
Item 4. Mine Safety Disclosures
Part II
Item 5. Market for Registrant's Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities
Item 6. Selected Financial Data
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
Item 8. Financial Statements and Supplementary Data
Note 1 - Summary of Significant Accounting Policies and Related Information
Note 2 - New Accounting Pronouncements
Note 3 - Revenue Recognition
Note 4 - Leases
Note 5 - Assets Held for Sale
Note 7 - Property and Equipment
Note 8 - Accrued Expenses and Other Current Liabilities
Note 9 - Drybar Products Acquisition
Note 10 - Goodwill and Intangibles
Note 11 - Share - Based Compensation Plans
Note 12 - Defined Contribution Plans
Note 13 - Repurchase of Helen of Troy Common Stock
Note 14 - Restructuring Plan
Note 15 - Other Commitments and Contingencies
Note 16 - Long Term Debt
Note 17 - Fair Value
Note 18 - Financial Instruments and Risk Management
Note 19 - Accumulated Other Comprehensive Income (Loss)
Note 20 - Segment and Geographic Information
Note 21 - Selected Quarterly Financial Data (Unaudited)
Note 22 - Income Taxes
Note 23 - Earnings per Share
Note 24 - Subsequent Events
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
Item 9A. Controls and Procedures
Part III
Item 10. Directors, Executive Officers and Corporate Governance
Item 11. Executive Compensation
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters
Item 13. Certain Relationships and Related Transactions, and Director Independence
Item 14. Principal Accounting Fees and Services
Part IV
Item 15. Exhibits, Financial Statement Schedules
EX-4.1 fy20q410kexhibit41-1.htm
EX-21 fy20q410kexhibit21.htm
EX-23.1 fy20q410kexhibit231.htm
EX-31.1 fy20q410kexhibit311.htm
EX-31.2 fy20q410kexhibit312.htm
EX-32 fy20q410kexhibit32.htm

Helen of Troy Earnings 2020-02-29

Balance SheetIncome StatementCash Flow
1.91.51.10.80.40.02012201420172020
Assets, Equity
0.50.40.30.10.0-0.12012201420172020
Rev, G Profit, Net Income
0.20.10.0-0.1-0.2-0.32012201420172020
Ops, Inv, Fin

Document
false--02-29FY2020000091678920320001461000P2YP18M0.00300.01250.00000.00000.00300.05390.00000.001521150002167000P9M18D4030000000.105000000050000000249460462519376624946046251937660.110.10148855000447400000000.0480.0230.0550.0280.0550.02619000001900000us-gaap:AccruedLiabilitiesCurrent1.001.0020000002000000001920021415419001750222024000 0000916789 2019-03-01 2020-02-29 0000916789 dei:OtherAddressMember 2019-03-01 2020-02-29 0000916789 2019-08-31 0000916789 2020-04-22 0000916789 2020-02-29 0000916789 2019-02-28 0000916789 2018-03-01 2019-02-28 0000916789 2017-03-01 2018-02-28 0000916789 us-gaap:CommonStockMember 2018-03-01 2019-02-28 0000916789 us-gaap:RetainedEarningsMember 2017-03-01 2018-02-28 0000916789 us-gaap:CommonStockMember 2017-03-01 2018-02-28 0000916789 us-gaap:RetainedEarningsMember 2019-02-28 0000916789 us-gaap:AdditionalPaidInCapitalMember 2019-03-01 2020-02-29 0000916789 us-gaap:AdditionalPaidInCapitalMember 2018-03-01 2019-02-28 0000916789 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-01 2019-02-28 0000916789 us-gaap:AdditionalPaidInCapitalMember 2019-02-28 0000916789 us-gaap:RetainedEarningsMember 2018-03-01 2019-02-28 0000916789 us-gaap:CommonStockMember 2017-02-28 0000916789 us-gaap:CommonStockMember 2019-03-01 2020-02-29 0000916789 us-gaap:AdditionalPaidInCapitalMember 2018-02-28 0000916789 us-gaap:AdditionalPaidInCapitalMember 2017-03-01 2018-02-28 0000916789 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-02-28 0000916789 us-gaap:RetainedEarningsMember 2017-02-28 0000916789 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-03-01 2018-02-28 0000916789 us-gaap:RetainedEarningsMember 2018-02-28 0000916789 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-02-28 0000916789 us-gaap:CommonStockMember 2018-02-28 0000916789 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-02-28 0000916789 us-gaap:RetainedEarningsMember 2020-02-29 0000916789 2018-03-01 0000916789 us-gaap:CommonStockMember 2019-02-28 0000916789 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-01 2020-02-29 0000916789 us-gaap:AdditionalPaidInCapitalMember 2017-02-28 0000916789 2017-02-28 0000916789 us-gaap:CommonStockMember 2020-02-29 0000916789 us-gaap:RetainedEarningsMember 2019-03-01 2020-02-29 0000916789 2018-02-28 0000916789 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-02-29 0000916789 us-gaap:AdditionalPaidInCapitalMember 2020-02-29 0000916789 us-gaap:RetainedEarningsMember 2018-03-01 0000916789 hele:SuppliersInFarEastMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2019-03-01 2020-02-29 0000916789 us-gaap:ShippingAndHandlingMember 2019-03-01 2020-02-29 0000916789 hele:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-03-01 2020-02-29 0000916789 hele:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-03-01 2020-02-29 0000916789 us-gaap:ShippingAndHandlingMember 2018-03-01 2019-02-28 0000916789 us-gaap:SalesRevenueNetMember us-gaap:RevenueFromRightsConcentrationRiskMember 2017-03-01 2018-02-28 0000916789 hele:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2018-03-01 2019-02-28 0000916789 hele:TopTwoSuppliersMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2018-03-01 2019-02-28 0000916789 us-gaap:SalesRevenueNetMember us-gaap:RevenueFromRightsConcentrationRiskMember 2019-03-01 2020-02-29 0000916789 hele:TopFiveSuppliersMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2019-03-01 2020-02-29 0000916789 us-gaap:ShippingAndHandlingMember 2017-03-01 2018-02-28 0000916789 hele:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2018-03-01 2019-02-28 0000916789 hele:TopFiveSuppliersMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2018-03-01 2019-02-28 0000916789 hele:TopSupplierMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2018-03-01 2019-02-28 0000916789 hele:SuppliersInFarEastMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2017-03-01 2018-02-28 0000916789 hele:TopLicensorMember us-gaap:SalesRevenueNetMember us-gaap:RevenueFromRightsConcentrationRiskMember 2019-03-01 2020-02-29 0000916789 hele:SuppliersInFarEastMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2018-03-01 2019-02-28 0000916789 hele:TopSupplierMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2019-03-01 2020-02-29 0000916789 srt:MinimumMember 2019-03-01 2020-02-29 0000916789 us-gaap:SalesRevenueNetMember us-gaap:RevenueFromRightsConcentrationRiskMember 2018-03-01 2019-02-28 0000916789 hele:TopLicensorMember us-gaap:SalesRevenueNetMember us-gaap:RevenueFromRightsConcentrationRiskMember 2018-03-01 2019-02-28 0000916789 hele:TopTwoSuppliersMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2017-03-01 2018-02-28 0000916789 srt:MaximumMember 2019-03-01 2020-02-29 0000916789 hele:TopTwoSuppliersMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2019-03-01 2020-02-29 0000916789 hele:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2018-03-01 2019-02-28 0000916789 hele:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-03-01 2020-02-29 0000916789 us-gaap:PatentsMember 2019-03-01 2020-02-29 0000916789 hele:TopFiveSuppliersMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2017-03-01 2018-02-28 0000916789 hele:DrybarProductsLLCMember 2020-01-23 2020-01-23 0000916789 hele:FiveTopCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-03-01 2020-02-29 0000916789 hele:TopLicensorMember us-gaap:SalesRevenueNetMember us-gaap:RevenueFromRightsConcentrationRiskMember 2017-03-01 2018-02-28 0000916789 hele:FiveTopCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2018-03-01 2019-02-28 0000916789 hele:TopSupplierMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2017-03-01 2018-02-28 0000916789 us-gaap:AccountingStandardsUpdate201602Member 2019-03-01 0000916789 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-02-28 0000916789 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-02-28 0000916789 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2017-03-01 2018-02-28 0000916789 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2017-03-01 2018-02-28 0000916789 us-gaap:AccountingStandardsUpdate201602Member 2020-02-29 0000916789 us-gaap:GoodwillMember 2020-02-29 0000916789 us-gaap:OtherIntangibleAssetsMember 2020-02-29 0000916789 us-gaap:InventoriesMember 2020-02-29 0000916789 us-gaap:PropertyPlantAndEquipmentMember 2020-02-29 0000916789 us-gaap:SegmentDiscontinuedOperationsMember hele:HealthyDirectionsLLCMember 2019-08-31 0000916789 us-gaap:SegmentDiscontinuedOperationsMember hele:HealthyDirectionsLLCMember 2017-12-31 0000916789 us-gaap:SegmentDiscontinuedOperationsMember hele:HealthyDirectionsLLCMember 2018-03-01 2019-02-28 0000916789 us-gaap:SegmentDiscontinuedOperationsMember hele:HealthyDirectionsLLCMember 2019-02-28 0000916789 us-gaap:SegmentDiscontinuedOperationsMember hele:HealthyDirectionsLLCMember 2017-12-01 2017-12-31 0000916789 us-gaap:SegmentDiscontinuedOperationsMember hele:HealthyDirectionsLLCMember 2019-03-01 2020-02-29 0000916789 us-gaap:ToolsDiesAndMoldsMember 2019-02-28 0000916789 us-gaap:ToolsDiesAndMoldsMember 2020-02-29 0000916789 srt:MaximumMember hele:ComputerFurnitureAndOtherEquipmentMember 2019-03-01 2020-02-29 0000916789 hele:ComputerFurnitureAndOtherEquipmentMember 2019-02-28 0000916789 us-gaap:LandMember 2019-02-28 0000916789 us-gaap:BuildingAndBuildingImprovementsMember 2019-02-28 0000916789 hele:ComputerFurnitureAndOtherEquipmentMember 2020-02-29 0000916789 us-gaap:ConstructionInProgressMember 2019-02-28 0000916789 us-gaap:BuildingAndBuildingImprovementsMember 2020-02-29 0000916789 us-gaap:LandMember 2020-02-29 0000916789 srt:MinimumMember us-gaap:BuildingAndBuildingImprovementsMember 2019-03-01 2020-02-29 0000916789 srt:MaximumMember us-gaap:ToolsDiesAndMoldsMember 2019-03-01 2020-02-29 0000916789 srt:MinimumMember hele:ComputerFurnitureAndOtherEquipmentMember 2019-03-01 2020-02-29 0000916789 srt:MinimumMember us-gaap:ToolsDiesAndMoldsMember 2019-03-01 2020-02-29 0000916789 srt:MaximumMember us-gaap:BuildingAndBuildingImprovementsMember 2019-03-01 2020-02-29 0000916789 us-gaap:ConstructionInProgressMember 2020-02-29 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-03-01 2018-02-28 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-03-01 2019-02-28 0000916789 us-gaap:CostOfSalesMember 2019-03-01 2020-02-29 0000916789 us-gaap:CostOfSalesMember 2017-03-01 2018-02-28 0000916789 us-gaap:CostOfSalesMember 2018-03-01 2019-02-28 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-03-01 2020-02-29 0000916789 hele:DrybarMember 2020-01-23 2020-02-29 0000916789 hele:DrybarMember 2020-01-23 0000916789 hele:DrybarMember us-gaap:TradeNamesMember 2020-01-23 0000916789 hele:DrybarMember us-gaap:OtherIntangibleAssetsMember 2020-01-23 0000916789 hele:DrybarMember 2018-03-01 2019-02-28 0000916789 hele:DrybarMember 2019-03-01 2020-02-29 0000916789 hele:DrybarMember us-gaap:CustomerRelationshipsMember hele:MeasurementInputRoyaltyRateMember 2020-01-23 2020-01-23 0000916789 hele:DrybarMember hele:ConsultingAgreementMember 2019-03-01 2020-02-29 0000916789 hele:DrybarMember us-gaap:TradeNamesMember hele:MeasurementInputRoyaltyRateMember 2020-01-23 2020-01-23 0000916789 hele:DrybarMember hele:MeasurementInputCustomerAttritionRateMember 2020-01-23 2020-01-23 0000916789 hele:DrybarMember us-gaap:TradeNamesMember 2020-02-29 0000916789 hele:DrybarMember hele:MeasurementInputWeightedAverageCostOfCapitalMember 2020-01-23 2020-01-23 0000916789 hele:DrybarMember us-gaap:CustomerRelationshipsMember 2019-03-01 2020-02-29 0000916789 hele:DrybarMember 2020-01-23 2020-01-23 0000916789 hele:DrybarMember us-gaap:TradeNamesMember 2019-03-01 2020-02-29 0000916789 hele:DrybarMember us-gaap:CustomerRelationshipsMember 2020-02-29 0000916789 hele:DrybarMember hele:ConsultingAgreementMember 2020-02-29 0000916789 hele:DrybarMember us-gaap:NoncompeteAgreementsMember 2019-03-01 2020-02-29 0000916789 hele:DrybarMember us-gaap:NoncompeteAgreementsMember 2020-02-29 0000916789 us-gaap:TrademarksMember hele:BeautySegmentMember 2020-02-29 0000916789 us-gaap:LicensingAgreementsMember hele:HealthHomeSegmentMember 2019-03-01 2020-02-29 0000916789 us-gaap:LicensingAgreementsMember hele:BeautySegmentMember 2019-02-28 0000916789 us-gaap:LicensingAgreementsMember hele:HealthHomeSegmentMember 2020-02-29 0000916789 hele:HousewaresSegmentMember 2019-02-28 0000916789 hele:BeautySegmentMember 2019-02-28 0000916789 us-gaap:OtherIntangibleAssetsMember hele:BeautySegmentMember 2019-03-01 2020-02-29 0000916789 hele:HealthHomeSegmentMember 2020-02-29 0000916789 us-gaap:LicensingAgreementsMember hele:BeautySegmentMember 2020-02-29 0000916789 us-gaap:TrademarksMember hele:BeautySegmentMember 2019-03-01 2020-02-29 0000916789 us-gaap:OtherIntangibleAssetsMember hele:HealthHomeSegmentMember 2019-03-01 2020-02-29 0000916789 us-gaap:LicensingAgreementsMember hele:BeautySegmentMember 2019-03-01 2020-02-29 0000916789 hele:BeautySegmentMember 2020-02-29 0000916789 us-gaap:OtherIntangibleAssetsMember hele:HousewaresSegmentMember 2020-02-29 0000916789 us-gaap:LicensingAgreementsMember hele:HealthHomeSegmentMember 2020-02-29 0000916789 us-gaap:TrademarksMember hele:HousewaresSegmentMember 2020-02-29 0000916789 us-gaap:TrademarksMember hele:BeautySegmentMember 2019-02-28 0000916789 hele:HousewaresSegmentMember 2020-02-29 0000916789 us-gaap:OtherIntangibleAssetsMember hele:HousewaresSegmentMember 2019-03-01 2020-02-29 0000916789 hele:BeautySegmentMember 2019-03-01 2020-02-29 0000916789 us-gaap:OtherIntangibleAssetsMember hele:BeautySegmentMember 2020-02-29 0000916789 us-gaap:LicensingAgreementsMember hele:HealthHomeSegmentMember 2019-02-28 0000916789 hele:HealthHomeSegmentMember 2019-03-01 2020-02-29 0000916789 us-gaap:LicensingAgreementsMember hele:BeautySegmentMember 2020-02-29 0000916789 hele:HousewaresSegmentMember 2019-03-01 2020-02-29 0000916789 us-gaap:TrademarksMember hele:BeautySegmentMember 2019-03-01 2020-02-29 0000916789 us-gaap:TrademarksMember hele:BeautySegmentMember 2019-02-28 0000916789 us-gaap:TrademarksMember hele:HealthHomeSegmentMember 2020-02-29 0000916789 us-gaap:LicensingAgreementsMember hele:BeautySegmentMember 2019-03-01 2020-02-29 0000916789 us-gaap:OtherIntangibleAssetsMember hele:HousewaresSegmentMember 2019-02-28 0000916789 hele:HealthHomeSegmentMember 2019-02-28 0000916789 us-gaap:TrademarksMember hele:HealthHomeSegmentMember 2019-02-28 0000916789 us-gaap:TrademarksMember hele:HousewaresSegmentMember 2019-02-28 0000916789 us-gaap:TrademarksMember hele:BeautySegmentMember 2020-02-29 0000916789 us-gaap:OtherIntangibleAssetsMember hele:BeautySegmentMember 2019-02-28 0000916789 us-gaap:LicensingAgreementsMember hele:HealthHomeSegmentMember 2019-02-28 0000916789 us-gaap:LicensingAgreementsMember hele:BeautySegmentMember 2019-02-28 0000916789 us-gaap:OtherIntangibleAssetsMember hele:HealthHomeSegmentMember 2019-02-28 0000916789 hele:OtherIntangibleAssetsIncludingHeldForSaleMember 2020-02-29 0000916789 us-gaap:OtherIntangibleAssetsMember hele:HealthHomeSegmentMember 2020-02-29 0000916789 us-gaap:GoodwillMember hele:BeautySegmentMember 2019-03-01 2020-02-29 0000916789 us-gaap:OtherIntangibleAssetsMember hele:BeautySegmentMember 2020-02-29 0000916789 hele:BeautySegmentMember 2017-03-01 2018-02-28 0000916789 hele:BeautySegmentMember 2018-03-01 2019-02-28 0000916789 us-gaap:OtherIntangibleAssetsMember hele:HealthHomeSegmentMember 2018-03-01 2019-02-28 0000916789 hele:BeautySegmentMember 2018-02-28 0000916789 us-gaap:OtherIntangibleAssetsMember hele:HousewaresSegmentMember 2018-02-28 0000916789 hele:HealthHomeSegmentMember 2018-03-01 2019-02-28 0000916789 hele:HousewaresSegmentMember 2018-03-01 2019-02-28 0000916789 hele:HealthHomeSegmentMember 2018-02-28 0000916789 us-gaap:LicensingAgreementsMember hele:BeautySegmentMember 2018-02-28 0000916789 us-gaap:LicensingAgreementsMember hele:HealthHomeSegmentMember 2018-02-28 0000916789 us-gaap:TrademarksMember hele:BeautySegmentMember 2018-03-01 2019-02-28 0000916789 us-gaap:LicensingAgreementsMember hele:BeautySegmentMember 2018-02-28 0000916789 us-gaap:LicensingAgreementsMember hele:BeautySegmentMember 2018-03-01 2019-02-28 0000916789 us-gaap:OtherIntangibleAssetsMember hele:HousewaresSegmentMember 2018-03-01 2019-02-28 0000916789 hele:HousewaresSegmentMember 2018-02-28 0000916789 us-gaap:OtherIntangibleAssetsMember hele:BeautySegmentMember 2018-03-01 2019-02-28 0000916789 us-gaap:LicensingAgreementsMember hele:HealthHomeSegmentMember 2018-03-01 2019-02-28 0000916789 us-gaap:OtherIntangibleAssetsMember hele:HealthHomeSegmentMember 2018-02-28 0000916789 us-gaap:TrademarksMember hele:HousewaresSegmentMember 2018-02-28 0000916789 us-gaap:LicensingAgreementsMember hele:HealthHomeSegmentMember 2018-02-28 0000916789 us-gaap:TrademarksMember hele:HealthHomeSegmentMember 2018-02-28 0000916789 us-gaap:TrademarksMember hele:BeautySegmentMember 2018-02-28 0000916789 us-gaap:TrademarksMember hele:BeautySegmentMember 2018-02-28 0000916789 us-gaap:OtherIntangibleAssetsMember hele:BeautySegmentMember 2018-02-28 0000916789 hele:StockOptionOfficersEmployeesAndConsultantsMember 2020-02-29 0000916789 hele:RestrictedStockUnitsAndPerformanceStockUnitsMember 2020-02-29 0000916789 hele:StockOptionOfficersEmployeesAndConsultantsMember 2019-03-01 2020-02-29 0000916789 hele:RestrictedStockUnitsAndPerformanceStockUnitsMember 2019-03-01 2020-02-29 0000916789 hele:PerformanceBasedAndOtherStockAwardsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-03-01 2019-02-28 0000916789 hele:PerformanceBasedAndOtherStockAwardsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-03-01 2020-02-29 0000916789 us-gaap:StockCompensationPlanMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:DirectorMember 2019-03-01 2020-02-29 0000916789 hele:StockOptionOfficersEmployeesAndConsultantsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-03-01 2019-02-28 0000916789 us-gaap:EmployeeStockMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-03-01 2019-02-28 0000916789 us-gaap:EmployeeStockMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-03-01 2018-02-28 0000916789 us-gaap:StockCompensationPlanMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:DirectorMember 2017-03-01 2018-02-28 0000916789 hele:StockOptionOfficersEmployeesAndConsultantsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-03-01 2020-02-29 0000916789 hele:PerformanceBasedAndOtherStockAwardsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-03-01 2018-02-28 0000916789 us-gaap:StockCompensationPlanMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:DirectorMember 2018-03-01 2019-02-28 0000916789 us-gaap:EmployeeStockMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-03-01 2020-02-29 0000916789 hele:StockOptionOfficersEmployeesAndConsultantsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-03-01 2018-02-28 0000916789 hele:The2018PlanMember 2019-03-01 2020-02-29 0000916789 us-gaap:RestrictedStockUnitsRSUMember hele:The2008DirectorPlanMember us-gaap:DirectorMember 2018-03-01 2019-02-28 0000916789 hele:RestrictedStockUnitsAndPerformanceStockUnitsMember hele:HelenOfTroyLimited2008StockIncentivePlanMember 2017-03-01 2018-02-28 0000916789 us-gaap:RestrictedStockUnitsRSUMember hele:The2018PlanMember 2019-03-01 2020-02-29 0000916789 us-gaap:RestrictedStockUnitsRSUMember hele:The2018PlanMember us-gaap:DirectorMember 2018-03-01 2019-02-28 0000916789 hele:RestrictedStockUnitsAndPerformanceStockUnitsMember hele:HelenOfTroyLimited2008StockIncentivePlanMember 2019-03-01 2020-02-29 0000916789 us-gaap:RestrictedStockUnitsRSUMember hele:The2008DirectorPlanMember us-gaap:DirectorMember 2017-03-01 2018-02-28 0000916789 us-gaap:RestrictedStockUnitsRSUMember hele:The2018PlanMember 2018-03-01 2019-02-28 0000916789 us-gaap:EmployeeStockMember 2019-03-01 2020-02-29 0000916789 hele:RestrictedStockUnitsAndPerformanceStockUnitsMember hele:HelenOfTroyLimited2008StockIncentivePlanMember 2018-03-01 2019-02-28 0000916789 us-gaap:RestrictedStockUnitsRSUMember hele:The2018PlanMember us-gaap:DirectorMember 2019-03-01 2020-02-29 0000916789 srt:MaximumMember us-gaap:EmployeeStockMember 2018-08-22 2018-08-22 0000916789 us-gaap:EmployeeStockMember 2018-08-22 0000916789 us-gaap:RestrictedStockUnitsRSUMember hele:The2018PlanMember us-gaap:DirectorMember 2017-03-01 2018-02-28 0000916789 hele:The2018PlanMember 2018-08-22 0000916789 us-gaap:RestrictedStockUnitsRSUMember hele:The2008DirectorPlanMember us-gaap:DirectorMember 2019-03-01 2020-02-29 0000916789 hele:RestrictedStockRSUsandRSAsMember hele:The2018PlanMember 2019-03-01 2020-02-29 0000916789 hele:The2018PlanMember 2020-02-29 0000916789 hele:PerformanceSharesPSUsandPSAsMember hele:The2018PlanMember 2019-03-01 2020-02-29 0000916789 us-gaap:RestrictedStockUnitsRSUMember hele:The2018PlanMember 2020-02-29 0000916789 us-gaap:RestrictedStockUnitsRSUMember hele:The2018PlanMember 2017-02-28 0000916789 us-gaap:RestrictedStockUnitsRSUMember hele:HelenOfTroyLimited2008StockIncentivePlanMember 2018-03-01 2019-02-28 0000916789 us-gaap:RestrictedStockUnitsRSUMember hele:The2018PlanMember 2017-03-01 2018-02-28 0000916789 us-gaap:RestrictedStockUnitsRSUMember hele:HelenOfTroyLimited2008StockIncentivePlanMember 2018-02-28 0000916789 us-gaap:RestrictedStockUnitsRSUMember hele:HelenOfTroyLimited2008StockIncentivePlanMember 2019-03-01 2020-02-29 0000916789 us-gaap:RestrictedStockUnitsRSUMember hele:HelenOfTroyLimited2008StockIncentivePlanMember 2019-02-28 0000916789 us-gaap:RestrictedStockUnitsRSUMember hele:HelenOfTroyLimited2008StockIncentivePlanMember 2017-03-01 2018-02-28 0000916789 us-gaap:RestrictedStockUnitsRSUMember hele:The2018PlanMember 2019-02-28 0000916789 us-gaap:RestrictedStockUnitsRSUMember hele:HelenOfTroyLimited2008StockIncentivePlanMember 2020-02-29 0000916789 us-gaap:RestrictedStockUnitsRSUMember hele:HelenOfTroyLimited2008StockIncentivePlanMember 2017-02-28 0000916789 us-gaap:RestrictedStockUnitsRSUMember hele:The2018PlanMember 2018-02-28 0000916789 us-gaap:RestrictedStockMember 2019-02-28 0000916789 us-gaap:RestrictedStockMember 2020-02-29 0000916789 us-gaap:PerformanceSharesMember 2020-02-29 0000916789 us-gaap:PerformanceSharesMember 2019-03-01 2020-02-29 0000916789 us-gaap:RestrictedStockMember 2019-03-01 2020-02-29 0000916789 us-gaap:PerformanceSharesMember 2019-02-28 0000916789 hele:StockOptionOfficersEmployeesAndConsultantsMember 2019-02-28 0000916789 hele:StockOptionOfficersEmployeesAndConsultantsMember 2018-02-28 0000916789 hele:StockOptionOfficersEmployeesAndConsultantsMember 2017-02-28 0000916789 hele:StockOptionOfficersEmployeesAndConsultantsMember 2017-03-01 2018-02-28 0000916789 hele:StockOptionOfficersEmployeesAndConsultantsMember 2018-03-01 2019-02-28 0000916789 hele:StockOptionOfficersEmployeesAndConsultantsMember 2016-03-01 2017-02-28 0000916789 2019-05-08 2019-05-08 0000916789 2019-05-08 0000916789 2019-05-31 0000916789 hele:OpenMarketAndTenderOfferMember 2018-03-01 2019-02-28 0000916789 hele:OpenMarketAndTenderOfferMember 2017-03-01 2018-02-28 0000916789 hele:OpenMarketAndTenderOfferMember 2019-03-01 2020-02-29 0000916789 srt:MaximumMember hele:ProjectRefuelMember 2019-03-01 2020-02-29 0000916789 hele:ProjectRefuelMember 2020-02-29 0000916789 hele:ProjectRefuelMember 2019-03-01 2020-02-29 0000916789 srt:MinimumMember hele:ProjectRefuelMember 2019-03-01 2020-02-29 0000916789 hele:ThermometerPatentLitigationMember us-gaap:SettledLitigationMember 2018-05-01 2018-05-31 0000916789 hele:LongTermIncentivePlanObligationsMember 2020-02-29 0000916789 hele:OperatingLeasesMember 2020-02-29 0000916789 us-gaap:CapitalAdditionsMember 2020-02-29 0000916789 us-gaap:PurchaseCommitmentMember 2020-02-29 0000916789 hele:AdvertisingAndPromotionalObligationsAndCommitmentsMember 2020-02-29 0000916789 hele:UnsecuredSeniorNotesFixedRateDebtMember 2020-02-29 0000916789 us-gaap:RoyaltyAgreementsMember 2020-02-29 0000916789 hele:InterestPayableOnFloatingRateTermDebtMember 2020-02-29 0000916789 us-gaap:LineOfCreditMember 2019-03-01 2020-02-29 0000916789 us-gaap:LineOfCreditMember 2018-03-01 2019-02-28 0000916789 us-gaap:LineOfCreditMember 2017-03-01 2018-02-28 0000916789 us-gaap:LineOfCreditMember 2018-02-28 0000916789 us-gaap:LineOfCreditMember 2019-02-28 0000916789 us-gaap:LineOfCreditMember 2020-02-29 0000916789 hele:UnsecuredStateIndustrialDevelopmentRevenueLoanMember us-gaap:BaseRateMember 2019-03-01 2020-02-29 0000916789 us-gaap:SubsequentEventMember 2020-03-13 2020-03-13 0000916789 srt:MinimumMember us-gaap:SubsequentEventMember us-gaap:EurodollarMember 2020-03-13 2020-03-13 0000916789 hele:UnsecuredStateIndustrialDevelopmentRevenueLoanMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-03-01 2020-02-29 0000916789 us-gaap:LineOfCreditMember 2020-02-29 0000916789 us-gaap:LineOfCreditMember us-gaap:SubsequentEventMember 2020-03-24 2020-03-24 0000916789 us-gaap:LineOfCreditMember us-gaap:SubsequentEventMember 2020-03-24 0000916789 hele:UnsecuredStateIndustrialDevelopmentRevenueLoanMember 2020-02-29 0000916789 srt:MaximumMember us-gaap:SubsequentEventMember us-gaap:BaseRateMember 2020-03-13 2020-03-13 0000916789 srt:MinimumMember us-gaap:SubsequentEventMember us-gaap:BaseRateMember 2020-03-13 2020-03-13 0000916789 us-gaap:LetterOfCreditMember us-gaap:LineOfCreditMember 2020-02-29 0000916789 us-gaap:LineOfCreditMember us-gaap:SubsequentEventMember 2020-03-13 0000916789 srt:MaximumMember us-gaap:SubsequentEventMember us-gaap:EurodollarMember 2020-03-13 2020-03-13 0000916789 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-02-29 0000916789 hele:UnsecuredStateIndustrialDevelopmentRevenueLoanMember 2019-02-28 0000916789 us-gaap:LineOfCreditMember 2019-02-28 0000916789 srt:MinimumMember us-gaap:LineOfCreditMember 2018-03-01 2019-02-28 0000916789 srt:MinimumMember us-gaap:LineOfCreditMember 2017-03-01 2018-02-28 0000916789 srt:MinimumMember us-gaap:LineOfCreditMember 2019-03-01 2020-02-29 0000916789 srt:MaximumMember us-gaap:LineOfCreditMember 2019-03-01 2020-02-29 0000916789 srt:MaximumMember us-gaap:LineOfCreditMember 2018-03-01 2019-02-28 0000916789 srt:MaximumMember us-gaap:LineOfCreditMember 2017-03-01 2018-02-28 0000916789 hele:OtherNonFinancialAssetsMember us-gaap:FairValueInputsLevel3Member 2018-02-28 0000916789 hele:OtherNonFinancialAssetsMember us-gaap:FairValueInputsLevel3Member 2018-03-01 2019-02-28 0000916789 hele:OtherNonFinancialAssetsMember us-gaap:FairValueInputsLevel3Member 2019-03-01 2020-02-29 0000916789 hele:OtherNonFinancialAssetsMember us-gaap:FairValueInputsLevel3Member 2019-02-28 0000916789 hele:OtherNonFinancialAssetsMember us-gaap:FairValueInputsLevel3Member 2020-02-29 0000916789 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-02-28 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-02-28 0000916789 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-02-29 0000916789 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2019-02-28 0000916789 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember hele:UnsecuredSeniorNotesFloatingInterestRateDebtMember 2019-02-28 0000916789 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-02-28 0000916789 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2020-02-29 0000916789 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember hele:UnsecuredSeniorNotesFloatingInterestRateDebtMember 2020-02-29 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-02-29 0000916789 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-02-29 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2019-03-01 2020-02-29 0000916789 hele:SegmentGeographicalGroupsOfCountriesNonUSDTransactionsMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2019-03-01 2020-02-29 0000916789 hele:UnsecuredSeniorNotes3.90PercentDueJan2018Member 2020-02-29 0000916789 currency:GBP us-gaap:OtherNoncurrentLiabilitiesMember hele:ZeroCostCollarContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-02-29 0000916789 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:NondesignatedMember 2020-02-29 0000916789 currency:GBP us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-02-29 0000916789 currency:GBP us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember hele:ZeroCostCollarContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-02-29 0000916789 currency:CAD us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-02-29 0000916789 currency:GBP us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-02-29 0000916789 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:NondesignatedMember 2020-02-29 0000916789 currency:EUR us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-02-29 0000916789 currency:GBP us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NondesignatedMember 2020-02-29 0000916789 us-gaap:OtherNoncurrentLiabilitiesMember 2020-02-29 0000916789 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-02-29 0000916789 currency:EUR hele:ZeroCostCollarContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-02-29 0000916789 currency:EUR us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember hele:ZeroCostCollarContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-02-29 0000916789 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-02-29 0000916789 us-gaap:OtherNoncurrentAssetsMember us-gaap:NondesignatedMember 2020-02-29 0000916789 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2020-02-29 0000916789 currency:EUR us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NondesignatedMember 2020-02-29 0000916789 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:NondesignatedMember 2020-02-29 0000916789 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2020-02-29 0000916789 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-02-29 0000916789 currency:GBP us-gaap:AccountsPayableAndAccruedLiabilitiesMember hele:ZeroCostCollarContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-02-29 0000916789 currency:GBP us-gaap:OtherNoncurrentAssetsMember hele:ZeroCostCollarContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-02-29 0000916789 currency:EUR us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-02-29 0000916789 currency:MXN us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-02-29 0000916789 currency:GBP us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-02-29 0000916789 currency:EUR us-gaap:OtherNoncurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NondesignatedMember 2020-02-29 0000916789 currency:GBP us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NondesignatedMember 2020-02-29 0000916789 currency:GBP hele:ZeroCostCollarContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-02-29 0000916789 currency:EUR us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NondesignatedMember 2020-02-29 0000916789 currency:CAD us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-02-29 0000916789 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-02-29 0000916789 currency:GBP us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NondesignatedMember 2020-02-29 0000916789 currency:EUR us-gaap:OtherNoncurrentLiabilitiesMember hele:ZeroCostCollarContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-02-29 0000916789 currency:EUR us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-02-29 0000916789 currency:GBP us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-02-29 0000916789 currency:EUR us-gaap:OtherNoncurrentAssetsMember hele:ZeroCostCollarContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-02-29 0000916789 currency:EUR us-gaap:AccountsPayableAndAccruedLiabilitiesMember hele:ZeroCostCollarContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-02-29 0000916789 currency:EUR us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NondesignatedMember 2020-02-29 0000916789 currency:GBP us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NondesignatedMember 2020-02-29 0000916789 us-gaap:OtherNoncurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-02-29 0000916789 us-gaap:OtherNoncurrentAssetsMember 2020-02-29 0000916789 currency:GBP us-gaap:OtherNoncurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NondesignatedMember 2020-02-29 0000916789 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-02-29 0000916789 currency:CAD us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-02-29 0000916789 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-02-29 0000916789 currency:MXN us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-02-29 0000916789 currency:EUR us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-02-29 0000916789 currency:CAD us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-02-29 0000916789 currency:CAD us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-02-29 0000916789 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-02-29 0000916789 currency:EUR us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-02-29 0000916789 currency:MXN us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-02-29 0000916789 currency:MXN us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-02-29 0000916789 currency:MXN us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-02-29 0000916789 currency:GBP us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-02-29 0000916789 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-02-29 0000916789 currency:EUR us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NondesignatedMember 2020-02-29 0000916789 us-gaap:CrossCurrencyInterestRateContractMember 2018-03-01 2019-02-28 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-03-01 2020-02-29 0000916789 us-gaap:CrossCurrencyInterestRateContractMember 2019-03-01 2020-02-29 0000916789 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember 2019-03-01 2020-02-29 0000916789 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:InterestExpenseMember 2018-03-01 2019-02-28 0000916789 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember 2018-03-01 2019-02-28 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-03-01 2019-02-28 0000916789 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2018-03-01 2019-02-28 0000916789 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2018-03-01 2019-02-28 0000916789 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-03-01 2020-02-29 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-03-01 2019-02-28 0000916789 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-03-01 2019-02-28 0000916789 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:InterestExpenseMember 2019-03-01 2020-02-29 0000916789 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2019-03-01 2020-02-29 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2018-03-01 2019-02-28 0000916789 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2019-03-01 2020-02-29 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-03-01 2020-02-29 0000916789 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-02-28 0000916789 currency:GBP us-gaap:OtherNoncurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NondesignatedMember 2019-02-28 0000916789 currency:EUR us-gaap:OtherNoncurrentAssetsMember hele:ZeroCostCollarContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-02-28 0000916789 currency:GBP us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-02-28 0000916789 currency:CAD us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-02-28 0000916789 currency:GBP us-gaap:OtherNoncurrentAssetsMember hele:ZeroCostCollarContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-02-28 0000916789 currency:EUR us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NondesignatedMember 2019-02-28 0000916789 currency:EUR us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-02-28 0000916789 currency:EUR us-gaap:OtherNoncurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NondesignatedMember 2019-02-28 0000916789 currency:GBP us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-02-28 0000916789 currency:GBP us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NondesignatedMember 2019-02-28 0000916789 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-02-28 0000916789 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-02-28 0000916789 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-02-28 0000916789 currency:EUR us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NondesignatedMember 2019-02-28 0000916789 currency:MXN us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-02-28 0000916789 currency:GBP us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NondesignatedMember 2019-02-28 0000916789 currency:EUR us-gaap:AccountsPayableAndAccruedLiabilitiesMember hele:ZeroCostCollarContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-02-28 0000916789 currency:CAD us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-02-28 0000916789 currency:CAD us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-02-28 0000916789 currency:EUR us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NondesignatedMember 2019-02-28 0000916789 currency:GBP us-gaap:AccountsPayableAndAccruedLiabilitiesMember hele:ZeroCostCollarContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-02-28 0000916789 currency:GBP us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-02-28 0000916789 us-gaap:OtherNoncurrentAssetsMember us-gaap:NondesignatedMember 2019-02-28 0000916789 currency:GBP hele:ZeroCostCollarContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-02-28 0000916789 currency:MXN us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-02-28 0000916789 currency:EUR us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-02-28 0000916789 currency:EUR us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-02-28 0000916789 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-02-28 0000916789 currency:GBP us-gaap:OtherNoncurrentLiabilitiesMember hele:ZeroCostCollarContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-02-28 0000916789 currency:EUR us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-02-28 0000916789 currency:EUR us-gaap:OtherNoncurrentLiabilitiesMember hele:ZeroCostCollarContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-02-28 0000916789 currency:CAD us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-02-28 0000916789 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-02-28 0000916789 currency:EUR us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NondesignatedMember 2019-02-28 0000916789 currency:EUR us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-02-28 0000916789 currency:GBP us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-02-28 0000916789 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:NondesignatedMember 2019-02-28 0000916789 currency:EUR us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember hele:ZeroCostCollarContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-02-28 0000916789 currency:EUR hele:ZeroCostCollarContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-02-28 0000916789 us-gaap:OtherNoncurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-02-28 0000916789 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-02-28 0000916789 currency:MXN us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-02-28 0000916789 currency:GBP us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-02-28 0000916789 currency:GBP us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NondesignatedMember 2019-02-28 0000916789 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:NondesignatedMember 2019-02-28 0000916789 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:NondesignatedMember 2019-02-28 0000916789 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2019-02-28 0000916789 currency:MXN us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-02-28 0000916789 us-gaap:OtherNoncurrentAssetsMember 2019-02-28 0000916789 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2019-02-28 0000916789 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-02-28 0000916789 us-gaap:OtherNoncurrentLiabilitiesMember 2019-02-28 0000916789 currency:GBP us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NondesignatedMember 2019-02-28 0000916789 currency:CAD us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-02-28 0000916789 currency:MXN us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-02-28 0000916789 currency:GBP us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember hele:ZeroCostCollarContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-02-28 0000916789 srt:MaximumMember us-gaap:CashMember 2018-03-01 2019-02-28 0000916789 srt:MaximumMember us-gaap:MoneyMarketFundsMember 2019-03-01 2020-02-29 0000916789 srt:MinimumMember us-gaap:CashMember 2019-03-01 2020-02-29 0000916789 srt:MinimumMember us-gaap:MoneyMarketFundsMember 2019-03-01 2020-02-29 0000916789 srt:MinimumMember us-gaap:CashMember 2018-03-01 2019-02-28 0000916789 srt:MaximumMember us-gaap:MoneyMarketFundsMember 2018-03-01 2019-02-28 0000916789 srt:MaximumMember us-gaap:CashMember 2019-03-01 2020-02-29 0000916789 srt:MinimumMember us-gaap:MoneyMarketFundsMember 2018-03-01 2019-02-28 0000916789 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-02-28 0000916789 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-03-01 2019-02-28 0000916789 us-gaap:AccumulatedTranslationAdjustmentMember 2018-02-28 0000916789 us-gaap:AccumulatedTranslationAdjustmentMember 2018-03-01 2019-02-28 0000916789 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-03-01 2020-02-29 0000916789 us-gaap:AccumulatedTranslationAdjustmentMember 2019-03-01 2020-02-29 0000916789 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-02-28 0000916789 us-gaap:AccumulatedTranslationAdjustmentMember 2019-02-28 0000916789 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-02-29 0000916789 us-gaap:AccumulatedTranslationAdjustmentMember 2020-02-29 0000916789 country:US 2020-02-29 0000916789 hele:SegmentGeographicalInternationalOutsideUSExcludingBarbadosMember 2018-02-28 0000916789 country:BB 2018-02-28 0000916789 country:BB 2019-02-28 0000916789 hele:SegmentGeographicalInternationalOutsideUSMember 2019-02-28 0000916789 country:US 2019-02-28 0000916789 hele:SegmentGeographicalInternationalOutsideUSMember 2020-02-29 0000916789 country:BB 2020-02-29 0000916789 hele:SegmentGeographicalInternationalOutsideUSExcludingBarbadosMember 2019-02-28 0000916789 hele:SegmentGeographicalInternationalOutsideUSMember 2018-02-28 0000916789 country:US 2018-02-28 0000916789 hele:SegmentGeographicalInternationalOutsideUSExcludingBarbadosMember 2020-02-29 0000916789 country:US us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2019-03-01 2020-02-29 0000916789 us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2018-03-01 2019-02-28 0000916789 us-gaap:EMEAMember 2017-03-01 2018-02-28 0000916789 srt:LatinAmericaMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2019-03-01 2020-02-29 0000916789 srt:AsiaPacificMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2017-03-01 2018-02-28 0000916789 country:CA us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2017-03-01 2018-02-28 0000916789 us-gaap:EMEAMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2019-03-01 2020-02-29 0000916789 country:US us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2018-03-01 2019-02-28 0000916789 srt:LatinAmericaMember 2017-03-01 2018-02-28 0000916789 srt:LatinAmericaMember 2019-03-01 2020-02-29 0000916789 country:CA us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2019-03-01 2020-02-29 0000916789 us-gaap:EMEAMember 2019-03-01 2020-02-29 0000916789 country:US us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2017-03-01 2018-02-28 0000916789 srt:LatinAmericaMember 2018-03-01 2019-02-28 0000916789 country:US 2017-03-01 2018-02-28 0000916789 us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2017-03-01 2018-02-28 0000916789 srt:AsiaPacificMember 2018-03-01 2019-02-28 0000916789 us-gaap:EMEAMember 2018-03-01 2019-02-28 0000916789 country:CA 2019-03-01 2020-02-29 0000916789 srt:AsiaPacificMember 2019-03-01 2020-02-29 0000916789 us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2019-03-01 2020-02-29 0000916789 srt:AsiaPacificMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2018-03-01 2019-02-28 0000916789 country:US 2018-03-01 2019-02-28 0000916789 country:CA us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2018-03-01 2019-02-28 0000916789 us-gaap:EMEAMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2017-03-01 2018-02-28 0000916789 country:US 2019-03-01 2020-02-29 0000916789 country:CA 2018-03-01 2019-02-28 0000916789 us-gaap:EMEAMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2018-03-01 2019-02-28 0000916789 srt:AsiaPacificMember 2017-03-01 2018-02-28 0000916789 country:CA 2017-03-01 2018-02-28 0000916789 srt:LatinAmericaMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2017-03-01 2018-02-28 0000916789 srt:AsiaPacificMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2019-03-01 2020-02-29 0000916789 srt:LatinAmericaMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2018-03-01 2019-02-28 0000916789 hele:ThirdLargestCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2018-03-01 2019-02-28 0000916789 hele:FiveTopCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2019-03-01 2020-02-29 0000916789 hele:FiveTopCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2017-03-01 2018-02-28 0000916789 us-gaap:DiscontinuedOperationsHeldforsaleMember hele:BeautySegmentMember 2020-02-29 0000916789 hele:SecondLargestCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2019-03-01 2020-02-29 0000916789 hele:FirstLargestCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2019-03-01 2020-02-29 0000916789 hele:SecondLargestCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2018-03-01 2019-02-28 0000916789 hele:FirstLargestCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2018-03-01 2019-02-28 0000916789 hele:SecondLargestCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2017-03-01 2018-02-28 0000916789 hele:FirstLargestCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2017-03-01 2018-02-28 0000916789 hele:FiveTopCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2018-03-01 2019-02-28 0000916789 hele:HousewaresSegmentMember 2017-03-01 2018-02-28 0000916789 hele:HealthHomeSegmentMember 2017-03-01 2018-02-28 0000916789 hele:ThirdLargestCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2017-03-01 2018-02-28 0000916789 2019-03-01 2019-05-31 0000916789 2018-09-01 2018-11-30 0000916789 2019-12-01 2020-02-29 0000916789 2019-06-01 2019-08-31 0000916789 2018-12-01 2019-02-28 0000916789 2018-03-01 2018-05-31 0000916789 2019-09-01 2019-11-30 0000916789 2018-06-01 2018-08-31 0000916789 us-gaap:ForeignCountryMember 2020-02-29 0000916789 us-gaap:StateAndLocalJurisdictionMember 2020-02-29 0000916789 us-gaap:SubsequentEventMember 2020-03-24 0000916789 us-gaap:AllowanceForCreditLossMember 2018-02-28 0000916789 us-gaap:AllowanceForCreditLossMember 2017-03-01 2018-02-28 0000916789 us-gaap:AllowanceForCreditLossMember 2018-03-01 2019-02-28 0000916789 us-gaap:AllowanceForCreditLossMember 2019-02-28 0000916789 us-gaap:AllowanceForCreditLossMember 2019-03-01 2020-02-29 0000916789 us-gaap:AllowanceForCreditLossMember 2017-02-28 0000916789 us-gaap:AllowanceForCreditLossMember 2020-02-29 xbrli:pure iso4217:USD hele:item xbrli:shares iso4217:USD xbrli:shares hele:Segment iso4217:EUR iso4217:GBP hele:Plan hele:Quarter

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended February 29, 2020
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission file number 001-14669
helenoftroylogoa02.jpg

HELEN OF TROY LIMITED
(Exact name of registrant as specified in its charter)

Bermuda     74-2692550
(State or other jurisdiction of incorporation or organization)    (I.R.S. Employer Identification No.)

Clarendon House, 2 Church Street, Hamilton, Bermuda                                    (Address of principal executive offices)            

1 Helen of Troy Plaza, El Paso, Texas             79912
(Registrant’s United States Mailing Address)            (Zip Code)
(915) 225-8000
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act: 
Title of each class
 
Trading Symbol
 
Name of each exchange on which registered
Common Shares, $0.10 par value per share
 
HELE
 
The NASDAQ Stock Market LLC
Securities registered pursuant to Section 12(g) of the Act: NONE
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes No
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.  Yes No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer                          Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   Yes No
The aggregate market value of the voting and non-voting common shares held by non-affiliates of the registrant as of August 31, 2019, based upon the closing price of the common shares as reported by The NASDAQ Global Select Market on such date, was approximately 3,831,315,388.
As of April 22, 2020, there were 25,243,702 common shares, $0.10 par value per share, outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the Proxy Statement for the 2020 Annual General Meeting of Shareholders to be filed within one hundred and twenty days of the fiscal year ended February 29, 2020 (2020 Proxy Statement) are incorporated by reference into Part III of this report to the extent described herein.



TABLE OF CONTENTS
 
 
 
 
PAGE
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

1


EXPLANATORY NOTE
In this report and the accompanying consolidated financial statements and notes, unless otherwise indicated or the context suggests otherwise, references to “the Company”, “our Company”, “Helen of Troy”, “we”, “us”, or “our” refer to Helen of Troy Limited and its subsidiaries. We refer to our common shares, par value $0.10 per share, as “common stock.” References to “EMEA” refer to the combined geographic markets of Europe, the Middle East and Africa. We use product and service names in this report for identification purposes only and they may be protected in the United States and other jurisdictions by trademarks, trade names, service marks, and other intellectual property rights of ours and other parties. The absence of a specific attribution in connection with any such mark does not constitute a waiver of any such right. All trademarks, trade names, service marks, and logos referenced herein belong to their respective owners. References to “fiscal” in connection with a numeric year number denotes our fiscal year ending on the last day of February, during the year number listed. References to “the FASB” refer to the Financial Accounting Standards Board. References to “GAAP” refer to U.S. generally accepted accounting principles. References to “ASU” refer to the codification of GAAP in the Accounting Standards Updates issued by the FASB. References to “ASC” refer to the codification of GAAP in the Accounting Standards Codification issued by the FASB.


2


PART I
Item 1. Business
Our Company
We incorporated in Texas in 1968 and were reorganized in Bermuda in 1994.  We are a leading global consumer products company offering creative solutions for our customers through a diversified portfolio of well-recognized and widely-trusted brands.  We have built leading market positions through new product innovation, product quality and competitive pricing.
Segment Information
We currently have three business segments, which are included in our financial statements in continuing operations:
Housewares:  Provides a broad range of products to help with food preparation, cooking, cleaning, organization, beverage service, and other tasks to ease everyday living for families. This segment sells primarily to retailers as well as through our direct-to-consumer channel.
Health & Home:  Provides healthcare and home environment products. Sales for the segment are primarily to retailers, with some direct-to-consumer channel sales.
Beauty:  Provides mass and prestige market personal care and beauty appliance products including hair styling appliances, grooming tools, decorative haircare accessories, and liquid, solid and powder-based personal care products.  This segment sells primarily to retailers, beauty supply wholesalers and directly to the consumer.
Unless otherwise indicated, all amounts are presented from continuing operations. Discontinued operations refers to our former Nutritional Supplements segment, which was divested on December 20, 2017. See Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") and Note 6 to the accompanying consolidated financial statements for more information. 
For more segment and geographic information concerning our net sales revenue, long-lived assets and operating income, refer to Note 20 to the accompanying consolidated financial statements.
Our Strategic Initiatives
In fiscal 2015, we launched a five-year transformational strategy designed to improve the performance of our business segments and strengthen our shared service capabilities.  This strategy has driven our decisions on where we will operate and how we will achieve our goals in markets around the world.  The overall design of our business and organizational plan is intended to create sustainable and profitable growth and improve organizational capability. 
Fiscal 2019 marked the completion of Phase I of our multi-year transformation strategy, which delivered performance across a wide range of measures. We improved organic sales growth by focusing on our Leadership Brands, made strategic acquisitions, became a more efficient operating company with strong global shared services, upgraded our organization and culture, improved inventory turns and return on invested capital, and returned capital to shareholders.

Fiscal 2020 began Phase II of our transformation and is designed to drive the next five years of progress. The long-term objectives of Phase II include improved organic sales growth, continued margin expansion, and strategic and effective capital deployment. We expect Phase II will include continued investment in our Leadership Brands, with a focus on growing them through consumer-centric innovation, expanding them more aggressively outside the United States, and adding new brands through acquisition. We anticipate building further shared service capability and operating efficiency, as well as attracting, retaining, unifying and training the best people.

3


On January 23, 2020, we completed the acquisition of Drybar Products LLC ("Drybar Products"), for approximately $255.9 million in cash, subject to certain customary closing adjustments. Drybar Products is a fast-growing, innovative, trend-setting prestige hair care and styling brand. As part of the transaction, we granted a worldwide license to Drybar Holdings LLC, the owner and long-time operator of Drybar blowout salons, to use the Drybar trademark in their continued operation of Drybar salons. The salons will exclusively use, promote, and sell Drybar products globally. The acquisition of Drybar Products adds an 8th Leadership Brand to the Company. Leadership Brands are brands which have number-one or number-two positions in their respective categories and, in addition to Drybar, include OXO, Honeywell, Braun, PUR, Hydro Flask, Vicks, and Hot Tools.
During the fourth quarter of fiscal 2020, we committed to a plan to divest certain assets within our mass market personal care business. The assets to be disposed of include intangible assets, inventory and fixed assets relating to our mass channel liquids, powder and aerosol products under brands such as Pert, Brut, Sure and Infusium. We expect the divestiture to occur within fiscal 2021. Accordingly, we have classified the identified assets of the disposal group as held for sale. The plan to divest these assets advances our strategy to focus our resources on our Leadership Brands.
Our Products
The following table summarizes the types of products we sell by business segment:
Segment
 
Product Category
 
Primary Products
Housewares
 
Food Preparation and Storage
 
Food preparation tools and gadgets, food storage containers and storage and organization products
 
 
Cleaning, Bath and Garden
 
Household cleaning products, shower organization, bathroom accessories, and gardening products
 
 
Infant and Toddler
 
Feeding and drinking products, child seating, cleaning tools and nursery accessories
 
 
Hot and Cold Beverage and Food Containers
 
Insulated water bottles, jugs, thermoses, drinkware, travel mugs and food containers
Health & Home
 
Healthcare
 
Thermometers, blood pressure monitors and humidifiers
 
 
Water Filtration
 
Faucet mount water filtration systems and pitcher based water filtration systems
 
 
Home Environment
 
Air purifiers, heaters, fans, humidifiers and dehumidifiers
Beauty
 
Appliances and Accessories (1)
 
Mass and prestige market hair and skin care appliances, grooming brushes, tools and decorative hair accessories
 
 
Personal Care (1)(2)
 
Mass and prestige market shampoos, liquid hair styling products, treatments and conditioners.
(1)
On January 23, 2020, we completed the acquisition of Drybar Products which offers innovative, trend setting prestige hair care and styling products.
(2)
During the fourth quarter of fiscal 2020, we committed to a plan to divest certain assets within our mass market personal care business. The assets to be disposed of include intangible assets, inventory and fixed assets relating to our mass channel liquids, powder and aerosol products. We have classified the identified assets as held for sale. For additional information see Note 5 to the accompanying consolidated financial statements.
Our Trademarks
We market products under a number of trademarks that we own and sell certain of our products under trademarks licensed from third parties.  We believe our principal trademarks, both owned and licensed, have high levels of brand name recognition among retailers and consumers throughout the world.  Through our favorable partnerships with our licensors, we believe we have developed stable, enduring relationships that provide access to unique brands that complement our owned and internally developed trademarks.
The Beauty and Health & Home segments rely on the continued use of trademarks licensed under various agreements for a substantial portion of their net sales revenue.  New product introductions under licensed trademarks require approval from the respective licensors.  The licensors must also approve the

4


product packaging.  Many of our license agreements require us to pay minimum royalties, meet minimum sales volumes and some require us to make minimum levels of advertising expenditures.
The following table lists our key trademarks by segment:
Segment
 
Owned
 
Licensed
Housewares
 
OXO, Good Grips, Hydro Flask, Soft Works, OXO tot
 
 
Health & Home
 
PUR
 
Honeywell, Braun, Vicks
Beauty
 
Drybar, Hot Tools, Brut, Pert, Sure, Infusium
 
Revlon, Bed Head
Patents and Other Intellectual Property
We maintain utility and design patents in the United States and several foreign countries.  We also protect certain details about our processes, products and strategies as trade secrets, keeping confidential the information that we believe provides us with a competitive advantage.
Sales and Marketing
We currently market our products in over 95 countries throughout the world. Sales within the United States comprised approximately 79%, 78% and 79% of total net sales revenue in fiscal 2020, 2019 and 2018, respectively. Our segments primarily sell their products through mass merchandisers, drugstore chains, warehouse clubs, home improvement stores, grocery stores, specialty stores, beauty supply retailers, e-commerce retailers, wholesalers, and various types of distributors, as well as directly to consumers.  We collaborate extensively with our retail customers and, in many instances, produce specific versions of our product lines with exclusive designs and packaging for their stores, which are appropriately priced for their respective customer bases.  We market products principally through the use of outside sales representatives and our own internal sales staff, supported by our internal marketing, category management, engineering, creative services, and customer and consumer service staff.  These groups work closely together to develop pricing and distribution strategies, to design packaging and to help develop product line extensions and new products.
Research and Development
Our research and development activities focus on new, differentiated and innovative products designed to drive sustained organic growth.  We continually invest to strengthen our product design and research and development capabilities, including extensive study to gain consumer insight.  Research and development expenses consist primarily of salary and employee benefit expenses and contracted development and testing efforts associated with development of products.
Manufacturing and Distribution
We contract with unaffiliated manufacturers, primarily in China and Mexico, to manufacture a significant portion of our finished goods for the Beauty appliances and accessories, Housewares, Healthcare, Water Filtration, and Home Environment product categories.  The North American region of the personal care category of the Beauty segment sources most of its products from U.S. manufacturers. Finished goods manufactured by vendors in the Far East comprised approximately 76%, 74% and 74% of finished goods purchased for fiscal 2020, 2019 and 2018, respectively.
We occupy owned and leased office and distribution space in various locations to support our operations.  These facilities include our U.S. headquarters in El Paso, Texas, and distribution centers in Southaven, Mississippi, and Olive Branch, Mississippi, which are used to support a significant portion of our domestic distribution.
Customers
Sales to our largest customer accounted for approximately 18%, 16% and 13% of our consolidated net sales revenue in fiscal 2020, 2019 and 2018, respectively.  Sales to our second largest customer

5


accounted for approximately 14%, 16% and 17% of our consolidated net sales revenue in fiscal 2020, 2019 and 2018, respectively.  Sales to our third largest customer did not account for 10% or more of our consolidated net sales revenue in fiscal 2020, however, did account for 10% of our consolidated net sales revenue in fiscal 2019 and 2018, respectively. No other customers accounted for 10% or more of consolidated net sales revenue during those fiscal years.  Sales to our top five customers accounted for approximately 50%, 51% and 49% of our consolidated net sales revenue in fiscal 2020, 2019 and 2018, respectively.
Order Backlog
When placing orders, our individual consumer, retail and wholesale customers usually request that we ship the related products within a short time frame.  As such, there usually is no significant backlog of orders in any of our distribution channels.

Seasonality
SEASONALITY AS A PERCENTAGE OF ANNUAL NET SALES REVENUE
 
Fiscal Years Ended Last Day of February
Fiscal Quarter Ended
2020
2019
2018
May
22.0
%
22.7
%
22.0
%
August
24.2
%
25.2
%
23.3
%
November
27.8
%
27.6
%
28.5
%
February
26.0
%
24.5
%
26.2
%

Our sales are seasonal due to different calendar events, holidays and seasonal weather patterns.  Historically, the third fiscal quarter produces the highest net sales revenue during the fiscal year.

Competitive Conditions

We generally sell our products in markets that are very competitive and mature.  Our products compete against similar products of many large and small companies, including well-known global competitors.  In many of the markets and industry segments in which we sell our products we compete against other branded products as well as retailers' private-label brands.  We believe that we have certain key competitive advantages, such as well recognized brands, engineering expertise and innovation, sourcing and supply chain know-how, and productive co-development relationships with our Far East manufacturers.  We support our products with advertising, promotions and other marketing activities, as well as an extensive sales force in order to build awareness and to encourage new consumers to try our brands and products.  We are well positioned in the industry segments and markets in which we operate, often holding a leadership or significant market share position.  We believe these advantages allow us to bring our retailers a differentiated value proposition.

The following table summarizes our primary competitors by business segment:
Segment
 
Competitor
Housewares
 
Lifetime Brands, Inc. (KitchenAid), Newell Brands Inc., Simple Human LLC, Yeti Holdings, Inc. (Yeti), Bradshaw Home, Inc. (BradshawHome)
Health & Home
 
Exergen Corporation, Omron Healthcare, Inc., Crane Engineering, Newell Brands, Inc., Lasko Products, LLC., The Clorox Company (Brita), Zero Technologies, LLC, Vornado Air Circulation Systems, Dyson Ltd, Unilever (Blueair), Guardian Technologies LLC.
Beauty
 
Conair, Spectrum Brands Holdings Inc. (Remington), Newell Brands, Inc., The Procter & Gamble Company, Unilever N.V., Colgate-Palmolive Company, Coty Inc., Dyson Ltd
Environmental and Health and Safety Matters
Our operations are subject to national, state, local, and provincial jurisdictions’ environmental, health and safety laws and regulations.  Many of the products we sell are subject to a number of product safety laws

6


and regulations in various jurisdictions.  These laws and regulations specify the maximum allowable levels of certain materials that may be contained in our products, provide statutory prohibitions against misbranded and adulterated products, establish ingredients and manufacturing procedures for certain products, specify product safety testing requirements, and set product identification and labeling requirements.
Additionally, an emerging trend with both governments and our retail customers is to prescribe public and private social accountability reporting requirements regarding our worldwide business activities.  In our product space, some requirements have already been mandated and we believe others may become required in the future.  Examples of current requirements include conflict minerals content reporting, customer reporting of foreign fair labor practices in connection with our supply chain vendors, and evaluating the risks of human trafficking and slavery.
We believe that we are in material compliance with these laws, regulations and other reporting requirements.  Further, the cost of maintaining compliance has not had a material adverse effect on our business, consolidated results of operations and consolidated financial condition, nor do we expect it to do so in the foreseeable future.  Due to the nature of our operations and the frequently changing nature of compliance and social reporting standards and technology, we cannot predict with any certainty that future material capital or operating expenditures will not be required in order to comply with applicable laws, regulations and other reporting mandates.
Employees
As of February 29, 2020, we employed approximately 1,650 full-time employees worldwide.  We also use temporary, part-time and seasonal employees as needed.  None of our U.S. employees are covered by a collective bargaining agreement.  Certain of our employees in Europe are covered by collective arrangements or works counsel in accordance with local practice.  We have never experienced a work stoppage, and we believe that we have satisfactory working relations with our employees.
Available Information
We maintain our main Internet site at: http://www.helenoftroy.com.  The information contained on this website is not included as a part of, or incorporated by reference into, this report.  We make available on or through our main website’s Investor Relations page under the heading “SEC Filings” certain reports and amendments to those reports that we file with, or furnish to, the SEC in accordance with the Securities Exchange Act of 1934, as amended (the “Exchange Act”).  These include our annual reports on Form 10-K, our quarterly reports on Form 10-Q, our current reports on Form 8-K, our proxy statements on Schedule 14A, amendments to these reports, and the reports required under Section 16 of the Exchange Act of transactions in our common stock by directors and officers.  We make this information available on our website free of charge as soon as reasonably practicable after we electronically file the information with, or furnish it to, the SEC.  Also, on the Investor Relations page, under the heading “Corporate Governance,” are our Code of Ethics, Code of Conduct, Corporate Governance Guidelines and the Charters of the Committees of the Board of Directors.

7


Item 1A. Risk Factors
Carefully consider the risks described below and all of the other information included in our report on Form 10-K when deciding whether to invest in our securities or otherwise evaluating our business. If any of the following risks or other events or circumstances described elsewhere in this report materialize, our business, operating results or financial condition may suffer. In this case, the trading price of our common stock and the value of your investment might significantly decline. The risks listed below are not the only risks that we face. Additional risks unknown to us or that we currently believe are insignificant may also affect our business.
We expect the current public health crisis resulting from the outbreak of novel coronavirus disease (commonly referred to as "COVID-19") to adversely impact our business, which could have a material impact on our operating results and financial condition. We must successfully manage the demand, supply, and operational challenges associated with the actual or perceived effects of COVID-19 and any similar future public health crisis, pandemic or epidemic.
Our business may be negatively impacted by the fear of exposure to, or actual effects of, pandemics and epidemics or similar public health crises. In response to a public health crisis, national, state and local authorities may implement a variety of measures to limit the spread of a disease, such as travel restrictions, social distancing or imposing quarantine and isolation measures on the population. The impacts of a public health crisis may include, but are not limited to:
Significant reductions in demand or significant volatility in demand for our products, which may be caused by, among other things, the temporary inability of consumers to purchase our products due to illness, self-quarantine, travel restrictions, financial hardship, restrictions that limit access to or close customer stores, or shifts in demand away from one or more of our more discretionary or higher priced products to lower priced products;
Inability to meet our customers’ needs and achieve costs targets due to disruptions in distribution capabilities or our supply chain caused by the loss or disruption of essential manufacturing and supply elements such as raw materials or other finished product components, restricted transportation or increased freight costs, reduced workforce, or other manufacturing sources and distribution processes; 
Failure of third parties on which we rely, including our suppliers, customers, distributors, commercial banks, and external business partners, to meet their obligations to us, or significant disruptions in their ability to do so, which may be caused by their own financial or operational difficulties and may adversely impact our operations; or
Significant changes in the political environment in which we manufacture, sell or distribute our products, including quarantines, governmental authority actions, closures or other restrictions that limit or close operating and manufacturing or distribution facilities, restrict employees’ ability to travel or perform necessary business functions, or otherwise prevent our external business partners, suppliers, or customers from sufficiently staffing operations, including operations necessary for the production, distribution, sale, and support of our products, which could adversely impact our results.

On March 13, 2020, the President of the United States announced a National Emergency relating to COVID-19. There is a possibility of widespread infection in the U.S. and abroad, with the potential for catastrophic impact. As a result of these and other effects, we expect COVID-19 to adversely impact our business, which could be material. The impact includes the effect of temporary closures of, and limited hours of operation and materially lower store traffic at, customer stores. The COVID-19 pandemic is also impacting our third-party manufacturers, most of which are located in the Far East, principally China. The extent of the impact of COVID-19 on our business and financial results will depend largely on future developments, including the duration of the spread of the COVID-19 outbreak within the U.S. and globally, the impact on capital and financial markets and the related impact on consumer confidence and spending. These future developments are outside of our control, are highly uncertain and cannot be predicted. If the impact is prolonged, then it can further increase the difficulty of planning for operations.

8


These and other potential impacts of the current public health crisis could therefore materially and adversely affect our business, financial condition, cash flows and results of operations. This situation is changing rapidly, and additional impacts may arise that we are not currently aware of. Accordingly, the results for the first quarter of fiscal 2021, as well as for the full fiscal 2021, could be impacted in ways that we are not able to predict today, including, but not limited to, non-cash write-downs and asset impairment charges (including impairments of goodwill and other indefinite-lived intangible assets).

Our ability to deliver products to our customers in a timely manner and to satisfy our customers’ fulfillment standards are subject to several factors, some of which are beyond our control.

Retailers place great emphasis on timely delivery of our products for specific selling seasons, especially during our third fiscal quarter, and on the fulfillment of consumer demand throughout the year. We cannot control all of the various factors that might affect product delivery to retailers. Vendor production delays, difficulties encountered in shipping from overseas, customs clearance delays, and operational issues with any of the third-party logistics providers we use in certain countries are on-going risks of our business. We also rely upon third-party carriers for our product shipments from our distribution centers to customers. In certain circumstances, we rely on the shipping arrangements our suppliers have made in the case of products shipped directly to retailers from the suppliers. Accordingly, we are subject to risks, including labor disputes, inclement weather, public health crises (such as pandemics and epidemics), natural disasters, possible acts of terrorism, availability of shipping containers, and increased security restrictions associated with the carriers’ ability to provide delivery services to meet our shipping needs. Further, our delivery process must often accommodate special vendor requirements to use specific carriers and delivery schedules. Failure to deliver products to our retailers in a timely and effective manner could damage our reputation and brands and result in the loss of customers or reduced orders, which could have a material adverse effect on our business, operating results and financial condition.
Large customers may take actions that adversely affect our gross profit and operating results.
With the continuing trend towards retail trade consolidation, we are increasingly dependent upon key customers whose bargaining strength is substantial and growing. We may be negatively affected by changes in the policies of our customers, such as actions to respond to a public health crisis, on-hand inventory reductions, limitations on access to shelf space, use of private label brands, price and term demands, and other conditions, which could negatively impact our business, operating results and financial condition.
In addition, the growth in e-commerce sales, both by large traditional retailers and pure-play online retailers, has increased the size and influence of these types of customers. Certain of these customers source and sell products under their own private label brands that compete with our products. As certain large customers and online retailers grow even larger and become more sophisticated, they may continue to demand lower pricing, special packaging, shorter lead times for the delivery of products, smaller more frequent shipments, or impose other requirements on product suppliers. These business demands may relate to inventory practices, logistics or other aspects of the customer-supplier relationship. If we do not effectively respond to these demands, these customers could decrease their purchases from us. A reduction in the demand for our products by these customers and the costs of complying with their business demands could have a material adverse effect on our business, operating results and financial condition.

9


We are subject to risks related to our dependence on the strength of retail economies and may be vulnerable in the event of a prolonged economic downturn, including from the effects of COVID-19.
Our business depends on the strength of the retail economies in various parts of the world, primarily in North America and to a lesser extent EMEA, Asia and Latin America. These retail economies are affected for the most part by factors such as consumer demand and the condition of the retail industry, which, in turn, are affected by general economic conditions and specific events such as natural disasters, public health crises (such as pandemics and epidemics), terrorist attacks and political unrest. Consumer spending in any geographic region is generally affected by a number of factors, including local economic conditions, government actions, inflation, interest rates, energy costs, unemployment rates, gasoline prices, and consumer confidence, all of which are beyond our control. Consumer purchases of discretionary items tend to decline during recessionary periods, when disposable income is lower, and may impact sales of our products. The COVID-19 pandemic has reduced consumer demand, and is expected to continue to do so. Measures imposed or that may in the future be imposed by national, state and local authorities in response to COVID-19 are expected to have serious adverse impacts of uncertain severity and duration on domestic and foreign economies. The effectiveness of economic stabilization efforts, including government payments and loans to affected citizens and industries, is uncertain. Some economists are predicting the U.S. may enter a recession as a result of the pandemic. Any sustained economic downturn in the U.S. or any of the other countries in which we conduct significant business, may cause significant readjustments in both the volume and mix of our product sales, which could materially and adversely affect our business, operating results and financial condition.
Our operating results are dependent on sales to several large customers and the loss of, or substantial decline in, sales to a top customer could have a material adverse effect on our revenues and profitability.
A few customers account for a substantial percentage of our net sales revenue. Our financial condition and operating results could suffer if we lost all or a portion of the sales to any one of these customers. In particular, sales to our two largest customers accounted for approximately 32% of our consolidated net sales revenue in fiscal 2020. While only two customers individually accounted for 10% or more of our consolidated net sales revenue in fiscal 2020, sales to our top five customers in aggregate accounted for approximately 50% of fiscal 2020 consolidated net sales revenue. We expect that a small group of customers will continue to account for a significant portion of our net sales revenue. Although we have long-standing relationships with our major customers, we generally do not have written agreements that require these customers to buy from us or to purchase a minimum amount of our products. A substantial decrease in sales to any of our major customers could have a material adverse effect on our financial condition and operating results. We expect that the creditworthiness of some of our customers may be vulnerable to the impact of the current public health crisis. We regularly monitor and evaluate the credit status of our customers and attempt to adjust sales terms as appropriate. Despite these efforts, a deterioration in the credit worthiness or bankruptcy filing of a key customer could have a material adverse effect on our business, operating results and financial condition.
Expectations regarding recent acquisitions, and any future acquisitions or divestitures, including our ability to realize related synergies, along with our ability to effectively integrate acquired businesses or disaggregate divested businesses, may adversely affect the price of our common stock.
We continue to look for opportunities to make strategic business and/or brand acquisitions. Additionally, we frequently evaluate our portfolio of business products and may consider divestitures or exits of businesses that we no longer believe to be an appropriate strategic fit. Our financial results could be impacted in the event that changes in the cash flows or other market-based assumptions or conditions cause the value of acquired assets to fall below book value, or we are not able to deliver the expected benefits or synergies associated with acquisition transactions, which could also have an impact on associated goodwill and intangible assets. Any acquisition or divestiture, if not favorably received by

10


consumers, shareholders, analysts, and others in the investment community, could have a material adverse effect on the price of our common stock.
In addition, any acquisition involves numerous risks, including:
difficulties in the assimilation of the operations, technologies, products, and personnel associated with the acquisitions;
challenges in integrating distribution channels;
diversion of management's attention from other business concerns;
difficulties in transitioning and preserving customer, contractor, supplier, and other important third-party relationships;
challenges realizing anticipated cost savings, synergies and other benefits related to an acquisition;
risks associated with subsequent losses or operating asset write-offs, contingent liabilities and impairment of related acquired intangible assets;
risks of entering markets in which we have no or limited experience; and
potential loss of key employees associated with the acquisitions.
If our goodwill, indefinite-lived intangible assets or other long-term assets become impaired, we will be required to record impairment charges, which may be significant.
A significant portion of our long-term assets consists of goodwill and other indefinite-lived intangible assets recorded as a result of past acquisitions. We do not amortize goodwill and indefinite-lived intangible assets, but rather review them for impairment on an annual basis or more frequently whenever events or changes in circumstances indicate that their carrying value may not be recoverable. If such circumstances or conditions exist, further steps are required in order to determine whether the carrying value of each of the individual assets exceeds its fair market value. If our analysis indicates that an individual asset’s carrying value does exceed its fair market value, the next step is to record a loss equal to the excess of the individual asset’s carrying value over its fair value. The analysis required by GAAP entails significant amounts of judgment and subjectivity.
We complete our analysis of the carrying value of our goodwill and other intangible assets during the fourth quarter of our fiscal year, or more frequently, whenever events or changes in circumstances indicate their carrying value may not be recoverable. Events and changes in circumstances that may indicate there is impairment and which may indicate interim impairment testing is necessary include, but are not limited to: strategic decisions to exit a business or dispose of an asset made in response to changes in economic, political and competitive conditions; the impact of the economic environment on our customer base and on broad market conditions that drive valuation considerations by market participants; our internal expectations with regard to future revenue growth and the assumptions we make when performing our impairment reviews; a significant decrease in the market price of our assets; a significant adverse change in the extent or manner in which our assets are used; a significant adverse change in legal factors or the business climate that could affect our assets; an accumulation of costs significantly in excess of the amount originally expected for the acquisition of an asset; and significant changes in the cash flows associated with an asset. We analyze these assets at the individual asset, reporting unit and company levels. As a result of such circumstances, we may be required to record a significant charge to net income in our financial statements during the period in which any impairment of our goodwill, indefinite-lived intangible assets or other long-term assets is determined. As a result of such circumstances and the current public health crisis, we may be required to revise certain accounting estimates and judgments such as those related to the valuation of goodwill and other indefinite-lived intangible assets, which could result in material non-cash impairment charges. Any such impairment charges could have a material adverse effect on our results of operations.

11


We rely on our Chief Executive Officer and a limited number of other key senior officers to operate our business. The loss of any of these individuals could have a material adverse effect on our business.
The loss of our Chief Executive Officer or any of our key senior officers could have a material adverse effect on our business, operating results and financial condition, particularly if we are unable to hire and integrate suitable replacements on a timely basis. Further, as we continue to grow our business, we will continue to adjust our senior management team. If we are unable to attract or retain the right individuals for the team, it could hinder our ability to grow our business and could disrupt our operations or otherwise have a material adverse effect on our business.
We rely on central Global Enterprise Resource Planning (“ERP”) systems and other peripheral information systems. Obsolescence or interruptions in the operation of our computerized systems or other information technologies could have a material adverse effect on our operations and profitability.
Our operations are largely dependent on our ERP system. We continuously make adjustments to improve the effectiveness of the ERP and other peripheral information systems, including the installation of significant new subsystems. Any failures or disruptions in the ERP and other information systems or any complications resulting from ongoing adjustments to our systems could cause interruption or loss of data in our information or logistical systems that could materially impact our ability to procure products from our factories and suppliers, transport them to our distribution centers, and store and deliver them to our customers on time and in the correct amounts. In addition, natural disasters or other extraordinary events may disrupt our information systems and other infrastructure, and our data recovery processes may not be sufficient to protect against loss.
Failure to maintain cybersecurity and the integrity of internal or customer data could have a material adverse effect on our operations and profitability and may result in faulty business decisions, operational inefficiencies, damage to our reputation and/or subject us to costs, fines, or lawsuits.
Information systems require constant updates to their security policies and hardware systems to reduce the risk of unauthorized access, malicious destruction of data or information theft. We rely on commercially available systems, software, tools, and monitoring to provide security for processing, transmission and storage of confidential information and data. While we have security measures in place, our systems and networks have been and will continue to be subject to ongoing threats. Therefore, our security measures may be breached as a result of employee error, failure to implement appropriate processes and procedures, advances in computer and software capabilities and encryption technology, new tools and discoveries, malfeasance, third-party action, including cyber-attacks or other international misconduct by computer hackers or otherwise. This could result in one or more third-parties obtaining unauthorized access to our customer or supplier data or our internal data, including personally identifiable information, intellectual property and other confidential business information. Third-parties may also attempt to fraudulently induce employees into disclosing sensitive information such as user names, passwords or other information in order to gain access to customer or supplier data or our internal data, including intellectual property and other confidential business information. Because techniques used to obtain unauthorized access or sabotage systems change frequently and generally are not identified until they are launched against a target, we may be unable to anticipate these techniques or to implement adequate preventative or mitigation measures. Though it is difficult to determine what harm may directly result from any specific interruption or breach, any failure to maintain performance, reliability, security and availability of our network infrastructure or otherwise to maintain the confidentiality, security, and integrity of data that we store or otherwise maintain on behalf of third-parties may harm our reputation and our customer and consumer relationships.
If such unauthorized disclosure or access does occur, we may be required to notify our customers, consumers, or those persons whose information was improperly used, disclosed or accessed. We may also be subject to claims of breach of contract for such use or disclosure, investigation and penalties by

12


regulatory authorities and potential claims by persons whose information was improperly used or disclosed. We could also become the subject of regulatory action or litigation from our consumers, customers, employees, suppliers, service providers, and shareholders, which could damage our reputation, require significant expenditures of capital and other resources, and cause us to lose business and revenue. Additionally, an unauthorized disclosure or use of information could cause interruptions in our operations and might require us to spend significant management time and other resources investigating the event and dealing with local and federal law enforcement. Regardless of the merits and ultimate outcome of these matters, we may be required to devote time and expense to their resolution. In addition, the increase in the number and the scope of data security incidents has increased regulatory and industry focus on security requirements and heightened data security industry practices. New regulation, evolving industry standards, and the interpretation of both, may cause us to incur additional expense in complying with any new data security requirements. As a result, the failure to maintain the integrity of and protect customer or supplier data or our internal data could have a material adverse effect on our business, operating results and financial condition.
Recent global legal developments regarding privacy and data security could result in changes to our business practices, penalties, increased cost of operations, or otherwise harm our business.
As a global company, we are subject to global privacy and data security laws, regulations, and codes of conduct that apply to our various business units. These laws and regulations may be inconsistent across jurisdictions and are subject to evolving and differing interpretations. Government regulators, privacy advocates and class action attorneys are increasingly scrutinizing how companies collect, process, use, store, share and transmit personal data. This increased scrutiny may result in new interpretations of existing laws, thereby further impacting our business.
Globally, new and emerging laws, such as the General Data Protection Regulation in Europe, state laws in the U.S. on privacy, data and related technologies, such as the California Consumer Privacy Act, as well as industry self-regulatory codes create new compliance obligations and expand the scope of potential liability, either jointly or severally with our customers and suppliers. While we have invested in readiness to comply with applicable requirements, these new and emerging laws, regulations and codes may affect our ability to reach current and prospective consumers, to respond to consumer requests under the laws (such as individual rights of access, correction, and deletion of their personal information), and to implement our business models effectively. The costs of compliance or failure to comply with such laws, regulations, codes of conduct and expectations could have a material adverse impact on our financial condition and results of operations.
Our operating results may be adversely affected by foreign currency exchange rate fluctuations.
Our functional currency is the U.S. Dollar. Changes in the relation of other foreign currencies to the U.S. Dollar will affect our sales and profitability and can result in exchange losses because we have operations and assets located outside the U.S. We transact a portion of our international business in currencies other than the U.S. Dollar (“foreign currencies”). Such transactions include sales, certain inventory purchases and operating expenses. As a result, portions of our cash, trade accounts receivable and trade accounts payable are denominated in foreign currencies. Accordingly, foreign operations will continue to expose us to foreign currency fluctuations, both for purposes of actual conversion and financial reporting purposes. Additionally, we purchase a substantial amount of our products from Chinese manufacturers in U.S Dollars. The Chinese Renminbi has fluctuated against the U.S. Dollar in recent years. During fiscal 2020 the Chinese Renminbi weakened against the U.S. dollar by approximately 5.0%. Chinese Renminbi currency fluctuations have the potential to add volatility to our product costs over time.
Where operating conditions permit, we seek to reduce foreign currency risk by purchasing most of our inventory with U.S. Dollars and by converting cash balances denominated in foreign currencies to U.S. Dollars. We use derivative financial instruments including forward contracts, cross currency debt swaps and zero-cost collars to hedge against certain foreign currency exchange rate-risk inherent in our transactions denominated in currencies other than the U.S. Dollar. We enter into these types of

13


agreements to partially mitigate our exposure to foreign currency exchange risk. It is not practical for us to hedge all our exposures, nor are we able to accurately project the possible effect of all foreign currency fluctuations on translated amounts or future net income due to our constantly changing exposure to various currencies, the fact that each foreign currency reacts differently to the U.S. Dollar and the significant number of currencies involved.

The impact of future foreign currency exchange rate fluctuations on our results of operations cannot be accurately predicted. Accordingly, there can be no assurance that foreign currency exchange rates:
will be stable in the future;
can be mitigated with currency hedging or other risk management strategies; or
will not have a material adverse effect on our business, operating results and financial condition.
Our judgments regarding the accounting for tax positions and the resolution of tax disputes may impact our net earnings and cash flow.
Significant judgment is required to determine our effective tax rate and evaluate our tax positions. We provide for uncertain tax positions when such tax positions do not meet the recognition thresholds or measurement criteria prescribed by applicable accounting standards. Fluctuations in federal, state, local and foreign taxes or a change to uncertain tax positions, including related interest and penalties, may impact our effective tax rate and financial results. Additionally, we are subject to audits in the various taxing jurisdictions in which we conduct business. In cases where audits are conducted and issues are raised, a number of years may elapse before such issues are finally resolved. Unfavorable resolution of any tax matter could increase the effective tax rate, which could have an adverse effect on our operating results and cash flow. For additional information regarding our taxes, see Note 22 to the accompanying consolidated financial statements.
Changes in laws, including tax laws, and the costs and complexities of compliance with such laws could have a material adverse impact on our business.
The impact of future legislation in the U.S. or abroad, including such things as employment and health insurance laws, climate change related legislation, tax legislation, regulations or treaties is always uncertain. Federal and local legislative agendas from time to time contain numerous proposals dealing with taxes, financial regulation, energy policy, environmental policy, transportation policy and infrastructure policy, among others that, if enacted into law, could increase our costs of doing business.

As additional regulatory guidance is issued by the applicable taxing authorities, accounting treatment is clarified, we perform additional analysis on the application of the law, and we refine estimates in calculating the effect, our final analysis may be different from provisional amounts, which could materially affect our tax obligations and effective tax rate in the period completed.
Under current tax law, favorable tax treatment of our non-U.S. income is dependent on our ability to avoid classification as a Controlled Foreign Corporation. Changes in the composition of our stock ownership could have an impact on our classification. If our classification were to change, it could have a material adverse effect on the largest U.S. shareholders and, in turn, on our business.
A non-U.S. corporation, such as ours, will constitute a “controlled foreign corporation” or “CFC” for U.S. federal income tax purposes if its largest U.S. shareholders together own more than 50 percent of the stock outstanding. A U.S. shareholder is defined as any U.S. person who owns directly, indirectly, or constructively: (1) 10 percent or more of the total combined voting power of all classes of stock, or (2) 10 percent or more of the total value of shares of all classes of stock. If the IRS or a court determined that we were a CFC at any time during the tax year, then each of our U.S. shareholders as defined above would be required to include in gross income for U.S. federal income tax purposes its pro rata share of our “subpart F income” (and the subpart F income of any of our subsidiaries determined to be a CFC) for

14


the period during which we (and our non-U.S. subsidiaries) were deemed a CFC. In addition, any gain on the sale of our shares realized by such a shareholder may be treated as ordinary income to the extent of the shareholder’s proportionate share of our and our CFC subsidiaries’ undistributed earnings and profits accumulated during the shareholder’s holding period of the shares while we were deemed to be a CFC.
Legislation enacted in Bermuda and Barbados in response to the European Union’s review of harmful tax competition could adversely affect our operations.

In December 2017, the EU Economic and Financial Affairs Council (“ECOFIN”) released a list of non-cooperative jurisdictions for tax purposes. The stated aim of this list, and accompanying report, was to promote good governance worldwide in order to maximize efforts to prevent tax fraud and tax evasion. Our jurisdiction of organization is Bermuda and one of our subsidiaries is organized in Barbados, two of the countries identified in the ECOFIN report. In light of recent “economic substance” legislation in Bermuda and Barbados (discussed in more detail below), ECOFIN has declared that both countries now “cooperate with the EU” and are considered to have “implemented all commitments.”

The economic substance legislation in each of Bermuda and Barbados requires certain entities engaged in “relevant activities” in that country to maintain a substantial economic presence in the country, and to satisfy economic substance requirements. The list of “relevant activities” in the respective statutes includes carrying on as a business any one or more of several enumerated activities, such as headquarters, shipping, distribution and service center, intellectual property and holding entities. Any entity that is required to satisfy economic substance requirements must file a declaration with the Bermuda Registrar of Companies and the Ministry of International Business and Industry in Barbados, as applicable. Failure to comply with the economic substance requirements could result in automatic disclosure of relevant information to competent authorities in the EU (and perhaps elsewhere). Other sanctions include financial penalties, restriction or regulation of business activities and/or being struck off as a registered entity in Bermuda or Barbados.

Although the local authorities have released some implementing guidelines, the impact of the foregoing legislation and developments is unclear, including how the requirements will be measured and whether additional or revised requirements may be enacted by Bermuda or Barbados. We are evaluating the guidelines and will be implementing changes as needed to comply with the legislation. However, we cannot predict the effect of Bermuda’s or Barbados’s current or future economic substance requirements on our business, which may impact the manner and jurisdictions in which we operate, and which could adversely affect our business, financial condition or results of operations.
Our business is subject to weather conditions, the duration and severity of the cold and flu season and other related factors, which can cause our operating results to vary from quarter to quarter and year to year.
Sales in our Health & Home segment are influenced by weather conditions. Sales volumes for thermometry, humidifiers and heating appliances are higher during, and subject to, the severity of the cold weather months, while sales of fans and insect control devices are higher during, and subject to, weather conditions in spring and summer months. Weather conditions can also more broadly impact sales across the organization. Additionally, natural disasters (such as wildfires, hurricanes and ice storms), public health crises (such as pandemics and epidemics), or unusually severe winter weather may result in temporary unanticipated fluctuations in retail traffic and consumer demand, may impact our ability to staff our distribution facilities or could otherwise impede timely transport and delivery of products from our distribution facilities. Sales in our Health & Home segment are also impacted by cough, cold and flu seasonal trends, including the duration and severity of the cold and flu season. These factors could have a material adverse effect on our business, operating results and financial condition.

15


We are dependent on third-party manufacturers, most of which are located in the Far East, and any inability to obtain products from such manufacturers could have a material adverse effect on our business, operating results and financial condition.
All of our products are manufactured by unaffiliated companies, most of which are in the Far East, principally in China. For fiscal 2020, finished goods manufactured in the Far East comprised approximately 76% of total finished goods purchased. This concentration exposes us to risks associated with doing business globally, including: global public health crises (such as pandemics and epidemics); changing international political relations; labor availability and cost; changes in laws, including tax laws, regulations and treaties; changes in labor laws, regulations and policies; changes in customs duties, additional tariffs and other trade barriers; changes in shipping costs; currency exchange fluctuations; local political unrest; an extended and complex transportation cycle; the impact of changing economic conditions; and the availability and cost of raw materials and merchandise. The political, legal and cultural environment in the Far East is rapidly evolving, and any change that impairs our ability to obtain products from manufacturers in that region, or to obtain products at marketable rates, could have a material adverse effect on our business, operating results and financial condition.
The current global public health crisis has disrupted our ability to receive manufactured products from the Far East and has disrupted our suppliers located elsewhere who rely on products from the Far East. Temporary factory closures and the pace of workers returning to work could further impact our suppliers' ability to source certain raw materials and to produce and fulfill finished goods orders in a timely manner. If we continue to experience supply disruptions as a result of the global public health crisis, we may not be able to develop short-term sourcing alternatives. Any disruption to our supply chain, even for a relatively short period of time, could cause a loss of revenue, which could adversely affect our operating results.
With most of our manufacturers located in the Far East, our production lead times are relatively long. Therefore, we must commit to production in advance of customer orders. If we fail to forecast customer or consumer demand accurately, we may encounter difficulties in filling customer orders on a timely basis or in liquidating excess inventories. We may also find that customers are canceling orders or returning products. Any of these results could have a material adverse effect on our business, operating results and financial condition.
Increased costs of raw materials and energy may adversely affect our operating results and cash flow.
Significant increases in the costs and availability of raw materials and energy may negatively affect our operating results. Our suppliers purchase significant amounts of metals and plastics to manufacture our products. In addition, they also purchase significant amounts of electricity to supply the energy required in their production processes. Middle East tensions and related political instabilities may drive up fuel prices resulting in higher transportation prices and product costs.
The cost of these raw materials and energy, in the aggregate, represents a significant portion of our cost of goods sold and certain operating expenses, which we may not be able to pass on to our customers. Our operating results could be adversely affected by future increases in these costs. Additionally, the loss or disruption of essential manufacturing and supply elements such as raw materials or other finished product components, restricted transportation or increased freight costs, reduced workforce, or other manufacturing and distribution disruption could adversely impact our ability to meet our customers’ needs.

16


If significant tariffs or other restrictions are placed on imports from China or any retaliatory trade measures are taken by China, our business and results of operations could be materially and adversely affected.

We purchase our products from unaffiliated manufacturers, most of which are located in China, Mexico and the U.S. This concentration exposes us to risks associated with doing business globally, including changes in tariffs. Any alteration of trade agreements and terms between China and the U.S., including limiting trade with China, imposing additional tariffs on imports from China and potentially imposing other restrictions on exports from China to the U.S. may result in further and or higher tariffs, or retaliatory trade measures by China, all of which could have a material adverse effect on our business and operating results.

Certain of our U.S. distribution facilities are geographically concentrated and operate during peak shipping periods at or near capacity. These factors increase our risk that disruptions could occur and significantly affect our ability to deliver products to our customers in a timely manner. Such disruptions could have a material adverse effect on our business.
Most of our U.S. distribution, receiving and storage functions are consolidated into two distribution facilities in northern Mississippi. Approximately 67% of our consolidated gross sales volume shipped from facilities in this region in fiscal 2020. For this reason, any disruption in our distribution process in either of these facilities, even for a few days, could adversely affect our business, operating results and financial condition. For example, in connection with the current public health crisis, government mandated or suggested isolation protocols could limit or disrupt the distribution process at either facility, or even cause the closure of either facility, which could have a material adverse effect on our business, operating results and financial condition.
Additionally, our U.S. distribution operations may incur capacity constraints during peak shipping periods as we continue to grow our sales revenue through a combination of organic growth and acquisitions. These and other factors described above could cause delays in the delivery of our products and increases in shipping and storage costs that could have a material and adverse effect on our business, operating results and financial condition.
Our projections of product demand, sales and net income are highly subjective in nature and our future sales and net income could vary in a material amount from our projections.
From time to time, we may provide financial projections to our shareholders, lenders, investment community, and other stakeholders of our future sales and net income. Since we do not require long-term purchase commitments from our major customers and the customer order and ship process is very short, it is difficult for us to accurately predict the demand for many of our products, or the amount and timing of our future sales, related net income and cash flows.
Our projections are based on management’s best estimate of sales using historical sales data and other relevant information available at the time. These projections are highly subjective since sales to our customers can fluctuate substantially based on the demand of their retail consumers and related ordering patterns, as well as other risks described in this report. Additionally, changes in retailer inventory management strategies could make our inventory management more difficult. Due to these factors, our future sales and net income could vary materially from our projections.
The extent of the impact of the current public health crisis on our business and financial results will depend largely on future developments, including the duration of the spread of the COVID-19 outbreak within the U.S. and globally, the impact on capital and financial markets and the related impact on consumer confidence and spending, all of which are highly uncertain and cannot be predicted. Consequently, these and other potential impacts could also cause future sales and net income to vary materially from our projections. This situation is changing rapidly, and additional impacts may arise that we are not currently aware of.

17


We rely on licensed trademarks from third parties and license certain trademarks to third parties in exchange for royalty income, the loss of which could have a material adverse effect on our revenues and profitability.
A substantial portion of our sales revenue comes from selling products under licensed trademarks, particularly in the Beauty and Health & Home segments. As a result, we are dependent upon the continued use of these trademarks. Additionally, we license certain owned trademarks to third parties in exchange for royalty income. It is possible that certain actions taken by us, our licensors, licensees, or other third parties might diminish greatly the value of any of our licensed trademarks. Some of our licensors and licensees also have the ability to terminate their license agreements with us at their option subject to each parties’ right to continue the license for a limited period of time following notice of termination. If we or our licensees were unable to sell products under these licensed trademarks, or one or more of our license agreements were terminated or the value of the trademarks were diminished, the effect on our business, operating results and financial condition could be both negative and material.
To compete successfully, we must develop and introduce a continuing stream of innovative new products to meet changing consumer preferences.
Our long-term success in the competitive retail environment depends on our ability to develop and commercialize a continuing stream of innovative new products that meet changing consumer preferences and take advantage of opportunities sooner than our competition. We face the risk that our competitors will introduce innovative new products that compete with our products. There are numerous uncertainties inherent in successfully developing and commercializing new products on a continuing basis and new product launches may not deliver expected growth in sales or operating income. Additionally, the effects of COVID-19 could delay our development or introduction of new products or require us to make unexpected changes to our products. If we are unable to develop and introduce a continuing stream of competitive new products, it may have an adverse effect on our business, operating results and financial condition.
Our operating results may be adversely affected by trade barriers, exchange controls, expropriations, and other risks associated with domestic and foreign operations.
The economies of foreign countries important to our operations, including countries in Asia, EMEA and Latin America, could suffer slower economic growth or economic, social and/or political instability or hyperinflation in the future. Our international operations in countries in Asia, EMEA and Latin America, including manufacturing and sourcing operations (and the international operations of our customers), are subject to inherent risks which could adversely affect us. Additionally, there may be uncertainty resulting from recent political changes in the U.S. and abroad, the Brexit transition in the United Kingdom (the “U.K.”), ongoing terrorist activity, and other global events. The exit of the U.K. from European Union (the “EU”) membership (commonly referred to as “Brexit”) could cause disruptions to and create uncertainty surrounding our business, including affecting our relationships with our existing and future customers, suppliers and employees, which could have an adverse effect on our business, financial results and operations. These factors are outside of our control, but may nonetheless cause us to adjust our strategy in order to compete effectively in global markets.
The domestic and foreign risks of these changes include, among other things:
protectionist policies restricting or impairing the manufacturing, sales or import and export of our products;
new restrictions on access to markets;
lack of required infrastructure;
inflation (including hyperinflation) or recession;
changes in, and the burdens and costs of compliance with, a variety of U.S. and foreign laws and regulations, including tax laws, accounting standards, environmental laws, and occupational health and safety laws;

18


social, political or economic instability;
acts of war and terrorism;
natural disasters and public health crises, such as pandemics and epidemics (including COVID-19);
reduced protection of intellectual property rights in some countries;
increases in duties and taxation;
restrictions on transfer of funds or exchange of currencies;
currency devaluations;
expropriation of assets; and
other adverse changes in policies, including monetary, tax or lending policies, encouraging foreign investment or foreign trade by our host countries.
Should any of these events occur, our ability to sell or export our products or repatriate profits could be impaired, we could experience a loss of sales and profitability from our domestic or international operations, and/or we could experience a substantial impairment or loss of assets, any of which could materially and adversely affect our business, operating results and financial condition.
Our liquidity may be materially adversely affected by constraints in the capital and credit markets and limitations under our financing arrangements.
We need sufficient sources of liquidity to fund our working capital requirements, service our outstanding indebtedness and finance business opportunities. Without sufficient liquidity, we could be forced to curtail our operations, or we may not be able to pursue business opportunities. The principal sources of our liquidity are funds generated from operating activities, available cash, credit facilities, and other debt arrangements. If our sources of liquidity do not satisfy our requirements, we may need to seek additional financing. The future availability of financing will depend on a variety of factors, such as economic and market conditions, the reaction by banks and financial institutions to a public health crisis (such as pandemics and epidemics), the regulatory environment for banks and other financial institutions, the availability of credit and our reputation with potential lenders. Further, disruptions in national and international credit markets could result in limitations on credit availability, tighter lending standards, higher interest rates on consumer and business loans, and higher fees associated with obtaining and maintaining credit availability. Disruptions may also materially limit consumer credit availability and restrict credit availability to us and our customer base. In addition, in the event of disruptions in the financial markets, current or future lenders may become unwilling or unable to continue to advance funds under any agreements in place, increase their commitments under existing credit arrangements or enter into new financing arrangements. These factors could materially adversely affect our liquidity, costs of borrowing and our ability to pursue business opportunities or grow our business, and threaten our ability to meet our obligations as they become due. In addition, covenants in our debt agreements could restrict or delay our ability to respond to business opportunities, or in the event of a failure to comply with such covenants, could result in an event of default, which if not cured or waived, could have a material adverse effect on us.
Our business involves the potential for product recalls, product liability and other claims against us, which could materially and adversely affect our business, operating results and financial condition.
We are, from time to time, involved in various claims, litigation matters and regulatory proceedings that arise in the ordinary course of our business and that could have a material adverse effect on us. These matters may include personal injury and other tort claims, deceptive trade practice disputes, intellectual property disputes, product recalls, contract disputes, warranty disputes, employment and tax matters and other proceedings and litigation, including class actions. It is not possible to predict the outcome of pending or future litigation. As with any litigation, it is possible that some of the actions could be decided unfavorably, resulting in significant liability and, regardless of the ultimate outcome, can be costly to defend. Our results and our business could also be negatively impacted if one of our brands suffers substantial damage to its reputation due to a significant product recall or other product-related litigation

19


and if we are unable to effectively manage real or perceived concerns about the safety, quality, or efficacy of our products.
We also face exposure to product liability and other claims in the event that one of our products is alleged to have resulted in property damage, bodily injury or other adverse effects. Although we maintain liability insurance in amounts that we believe are reasonable, that insurance is, in most cases, subject to large self-insured retentions for which we are responsible. We cannot provide assurance that we will be able to maintain such insurance on acceptable terms, if at all in the future, or that product liability or other claims will not exceed the amount of insurance coverage, or that all such matters would be covered by our insurance. As a result, these types of claims could have a material adverse effect on our business, operating results and financial condition.
Significant changes in regulations or product certifications could adversely impact our operations.
As a global company, we are subject to U.S. and foreign regulations and industry-specific product certifications.  For example, thermometers distributed by our Health and Home segment must comply with various regulations governing the production and distribution of medical devices.  These regulations could vary from country to country.  Significant new regulations or material changes to existing regulations could delay or interrupt distribution of our products in certain countries.  Additionally, we cannot guarantee that our products will receive regulatory approval in all countries.  Similarly, some of our Beauty segment’s customers demand that our Beauty appliances comply with various safety certifications, including UL certifications.   Significant new certification requirements or changes to existing certification requirements could delay or interrupt distribution of our products, or make them more costly to produce. 

Item 1B. Unresolved Staff Comments
None.
Item 2. Properties
As of February 29, 2020, we own, lease or otherwise utilize through third-party management service agreements various properties worldwide for sales, procurement, research and development, administrative and distribution facilities. Our U.S. headquarters are located in El Paso, Texas, and we have two main distribution facilities in Southaven and Olive Branch, Mississippi, which service all of our segments. We believe our facilities are adequate to conduct our business.
Item 3. Legal Proceedings
We are involved in various legal claims and proceedings in the normal course of operations. In the opinion of management, the outcome of these matters will not have a material adverse effect on our consolidated financial position, operating results or liquidity. See Note 15 to the accompanying consolidated financial statements for a further discussion.

Item 4. Mine Safety Disclosures 
Not applicable.

20


PART II
Item 5. Market for Registrant's Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities
Market Information for Common Stock
Our common stock is listed on the NASDAQ Global Select Market under symbol: HELE.
Approximate Number of Equity Security Holders of Record
Our common stock is our only class of equity security outstanding at February 29, 2020. As of April 22, 2020, there were 136 holders of record of our common stock. A substantially greater number of holders of our common stock are “street name” or beneficial holders whose shares are held of record by banks, brokers and other financial institutions.
Cash Dividends
Our current policy is to retain earnings to provide funds for the operation and expansion of our business, common stock repurchases and for potential acquisitions. We have not paid any cash dividends on our common stock since inception. Any change in dividend policy will depend upon future conditions, including earnings and financial condition, general business conditions, any applicable contractual limitations, and other factors deemed relevant by our Board of Directors.
Issuer Purchases of Equity Securities
In May 2019, we announced that our Board of Directors had authorized the repurchase of up to $400 million of our outstanding common stock.  The authorization is effective May 8, 2019 for a period of three years and replaced Helen of Troy's previous repurchase authorization, of which approximately $107.4 million remained. These repurchases may include open market purchases, privately negotiated transactions, block trades, accelerated stock repurchase transactions, or any combination of such methods. The number of shares purchased and the timing of the purchases will depend on a number of factors, including share price, trading volume and general market conditions, working capital requirements, general business conditions, financial conditions, any applicable contractual limitations, and other factors, including alternative investment opportunities.  See Note 13 to the accompanying consolidated financial statements for additional information.
Our current equity-based compensation plans include provisions that allow for the “net exercise” of share-settled awards by all plan participants.  In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the equity holder can be paid for by having the equity holder tender back to the Company a number of shares at fair value equal to the amounts due.  Net exercises are treated as purchases and retirements of shares.
Share repurchase activity during the three-month period ended February 29, 2020, was as follows:
Period
 
Total Number of
Shares Purchased (1)
 
Average Price
Paid per Share
 
Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs
 
Maximum Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs
(in thousands) (2)
December 1 through December 31, 2019
 
171

 
$
158.40

 
171

 
$
392,986

January 1 through January 31, 2020
 
34

 
188.32

 
34

 
392,979

February 1 through February 29, 2020
 

 

 

 
392,979

Total
 
205

 
$
163.36

 
205

 
 

21


(1)
The number of shares above includes shares of common stock acquired from employees who tendered shares to: 1) satisfy the tax withholding on equity awards as part of our long-term incentive plans or 2) satisfy the exercise price on stock option exercises. For the three-month period ended February 29, 2020 and the full fiscal year 2020, 205 and 77,272 shares were acquired from employees at a weighted average per share price of $163.36 and $131.61, respectively.
(2)
Reflects the remaining dollar value of shares that may yet be purchased under our Stock Repurchase Plan through the end of February 29, 2020 as authorized by the Company's Board of Directors in May 2019. For additional information, see Note 13 to the accompanying consolidated financial statements.
The following table summarizes our share repurchase activity for the periods shown:
(in thousands, except share and per share data)
Fiscal Years Ended
Last Day of February,
 
2020
 
2019
 
2018
Common stock repurchased on the open market:
 
 
 
 
 
Number of shares

 
1,875,469

 
717,300

Aggregate value of shares
$

 
$
212,080

 
$
65,795

Average price per share
$

 
$
113.08

 
$
91.73

 
 
 
 
 
 
Common stock received in connection with share-based compensation:
 

 
 

 
 

Number of shares
77,272

 
59,024

 
75,785

Aggregate value of shares
$
10,169

 
$
5,413

 
$
7,258

Average price per share
$
131.61

 
$
91.70

 
$
95.77


22


Performance Graph

The graph below compares the cumulative total return of our Company to the NASDAQ Market Index and a Peer Group Index, assuming $100 was invested on February 27, 2015. The Peer Group Index is the Dow Jones - U.S. Personal Products, Broad Market Cap, Yearly, and Total Return Index. The comparisons in this table are required by the SEC and are not intended to forecast or be indicative of the possible future performance of our common stock.

stockchart.jpg
The Performance Graph shall not be deemed to be “soliciting material” or to be “filed” with the SEC or subject to the liabilities of Section 18 under the Exchange Act. In addition, it shall not be deemed incorporated by reference by any statement that incorporates this annual report on Form 10-K by reference into any filing under the Securities Act of 1933 or the Exchange Act, except to the extent that we specifically incorporate this information by reference.


23


Item 6. Selected Financial Data 

The selected consolidated statements of income and cash flow data for fiscal 2020, 2019 and 2018, and the selected consolidated balance sheet data as of the end of fiscal 2020 and 2019, have been derived from our audited consolidated financial statements included in this report. The selected consolidated statements of income and cash flow data for fiscal 2017 and 2016, and the selected consolidated balance sheet data as of the end of fiscal 2018, 2017 and 2016, have been derived from our audited consolidated financial statements, which are not included in this report. This information should be read together with the discussion in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our consolidated financial statements and notes to those statements included in this report. All currency amounts are denominated in U.S. Dollars. 

In December 2017, we sold our former Nutritional Supplements segment. The operating results of this segment are presented as discontinued operations for all applicable periods presented. Additional information related to the sale of our former Nutritional Supplement segment is included in Note 6 to the accompanying consolidated financial statements.

In January 2020, we completed the acquisition of Drybar Products LLC ("Drybar Products"), for approximately $255.9 million in cash, subject to certain customary closing adjustments. Fiscal 2020 includes approximately five weeks of operating results in the Beauty segment. See Note 9 to the accompanying consolidated financial statements.

In the fourth quarter of fiscal 2020, we committed to a plan to divest certain assets within our mass market personal care business. We expect the divestiture to occur within fiscal 2021. Accordingly, we have classified the identified assets of the disposal group as held for sale as of February 29, 2020. See Note 5 to the accompanying consolidated financial statements.


24


(in thousands, except per share data)
2020 (1)(2)(3)
2019 (1)(2)
2018 (1)(2)(4)
2017 (1)(2)(4)(5)
2016 (1)(2)(5)
Income Statement Data:
 

 

 

 

 

Housewares
$
640,965

$
523,807

$
459,004

$
418,558

311,023

Health & Home
685,397

695,217

674,062

626,982

637,427

Beauty
381,070

345,127

345,779

351,995

434,943

Sales revenue, net
1,707,432

1,564,151

1,478,845

1,397,535

1,383,393

Gross profit
734,466

641,106

611,199

573,416

516,551

Asset impairment charges
41,000


15,447

2,900

6,000

Restructuring charges
3,313

3,586

1,857



Operating income
178,251

199,379

169,062

169,664

116,294

Interest expense
12,705

11,719

13,951

14,361

10,581

Income tax expense
13,607

13,776

26,556

11,407

13,021

Income from continuing operations
152,333

174,224

128,882

144,310

92,991

Income (loss) from discontinued operations, net of tax

(5,679
)
(84,436
)
(3,621
)
8,237

Net income
152,333

168,545

44,446

140,689

101,228

Earnings (loss) per share - basic
 
 
 
 
 
Continuing operations
$
6.06

$
6.68

$
4.76

$
5.24

$
3.29

Discontinued operations

(0.22
)
(3.12
)
(0.13
)
0.29

Net income
$
6.06

$
6.46

$
1.64

$
5.11

$
3.58

Earnings (loss) per share - diluted
 
 
 
 
 
Continuing operations
$
6.02

$
6.62

$
4.73

$
5.17

$
3.23

Discontinued operations

(0.22
)
(3.10
)
(0.13
)
0.29

Net income
$
6.02

$
6.41

$
1.63

$
5.04

$
3.52

 
 
 
 
 
 
Weighted average shares outstanding - basic
25,118

26,073

27,077

27,522

28,273

Weighted average shares outstanding - diluted
25,322

26,303

27,254

27,891

28,749

 
 
 
 
 
 
Cash Flow Data from Continuing Operations:
 

 

 

 

 

Depreciation and amortization
$
37,409

$
29,927

$
33,730

$
36,175

$
34,889

Net cash provided by operating activities
271,293

200,568

218,609

212,491

170,263

Capital and intangible asset expenditures
17,759

26,385

13,605

15,507

16,676

Payments to acquire businesses, net of cash acquired
255,861



209,267

43,150

Repurchases of common stock(8)
10,169

217,493

73,053

75,595

106,411

Net amounts borrowed (repaid)
16,900

29,900

(197,000
)
(133,200
)
190,700

(in thousands)
2020 (1)(2)(3)
2019 (1)(2)
2018 (1)(2)(4)
2017 (1)(2)(4)(5)
2016 (1)(2)(5)
Balance Sheet Data from Continuing Operations:
 

 

 

 

 

Working capital (6)(7)
$
343,940

$
292,828

$
258,222

$
267,896

$
487,861

Goodwill and other intangible assets(6)(7)
1,040,853

893,846

905,235

938,324

762,879

Total assets (6)(7)
1,903,883

1,649,535

1,623,717

1,616,235

1,639,673

Long-term debt, excluding current maturities
337,421

318,900

287,985

461,211

600,107

Stockholders' equity (8)
1,161,723

996,637

1,014,459

1,020,766

930,043

(1)
We adopted ASU 2014-09, Revenue from Contracts with Customers (Topic 606) in the first quarter of fiscal 2019 and have reclassified amounts in the prior year’s statements of income to conform to the current period’s presentation. For additional information see Note 3 to the accompanying consolidated financial statements.
(2)
In December 2017, we divested our former Nutritional Supplements segment, which is reported as discontinued operations. For additional information see Note 6 to the accompanying consolidated financial statements.
(3)
Fiscal 2020 includes approximately five weeks of operating results from the acquisition of Drybar Products, acquired on January 23, 2020, for a net cash purchase of approximately $255.9 million. For additional information see Note 9 to the accompanying consolidated financial statements.
(4)
Fiscal 2017 includes eleven and one-half months of operating results from the acquisition of Hydro Flask, acquired for a net cash purchase price of $209.3 million. Fiscal 2018 and thereafter includes a full year of operating results.

25


(5)
Fiscal 2016 includes eleven months of operating results from the Vicks VapoSteam inhalant business acquired for a net cash purchase price of $42.8 million. Fiscal 2017 and thereafter includes a full year of operating results.
(6)
In the fourth quarter of fiscal 2020, we committed to a plan to divest certain assets within our mass market personal care business. We expect the divestiture to occur within fiscal 2021. Fiscal 2020 includes assets classified as "held for sale" of $44.8 million related to our mass market personal care business.
(7)
Fiscal 2016 includes certain reclassifications to conform with fiscal 2017 adopted accounting changes. 
(8)
During fiscal 2020, 2019, 2018, 2017 and 2016, we repurchased and retired 77,272, 1,934,493, 793,085, 929,017, and 1,244,090 shares of common stock having total cost of $10.2, $217.5, $73.1, $75.6, and $106.4 million, respectively. 
Information Regarding Forward-Looking Statements
Certain written and oral statements in this Form 10-K may constitute "forward-looking statements" as defined under the Private Securities Litigation Reform Act of 1995. This includes statements made in this report, in other filings with the Securities and Exchange Commission (the "SEC"), in press releases, and in certain other oral and written presentations. Generally, the words "anticipates", "believes", "expects", "plans", "may", "will", "should", "seeks", "estimates", "project", "predict", "potential", "continue", "intends", and other similar words identify forward-looking statements. All statements that address operating results, events or developments that may occur in the future, including statements related to sales, earnings per share ("EPS") results, and statements expressing general expectations about future operating results and the effect of the outbreak of a novel strain of the coronavirus (COVID-19) on our financial results, cash flows and operations, are forward-looking statements and are based upon our current expectations and various assumptions. We believe there is a reasonable basis for our expectations and assumptions, but there can be no assurance that we will realize our expectations or that our assumptions will prove correct. Forward-looking statements are subject to risks that could cause them to differ materially from actual results. Accordingly, we caution readers not to place undue reliance on forward-looking statements. We believe that these risks include but are not limited to the risks described in this report under Item 1A., “Risk Factors” and that are otherwise described from time to time in our SEC reports as filed. We undertake no obligation to publicly update or revise any forward-looking statements as a result of new information, future events or otherwise.

26


Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations
This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) should be read in conjunction with the other sections of this report, including Part I, Item 1., “Business”; Part II, Item 6., “Selected Financial Data”; and Part II, Item 8., “Financial Statements and Supplementary Data.” The various sections of this MD&A contain a number of forward-looking statements, all of which are based on our current expectations. Actual results may differ materially due to a number of factors, including those discussed in Item 1A.,“Risk Factors,” and in the section entitled “Information Regarding Forward-Looking Statements,” preceding this MD&A, and in Item 7A., “Quantitative and Qualitative Disclosures About Market Risk.” Throughout MD&A, we refer to our Leadership Brands, which are brands that have number-one and number-two positions in their respective categories and include OXO, Honeywell, Braun, PUR, Hydro Flask, Vicks, Hot Tools and Drybar.
This MD&A, including the tables under the headings “Operating income, operating margin, adjusted operating income (non-GAAP) and adjusted operating margin (non-GAAP) by segment" and “Income from continuing operations, diluted earnings per share ("EPS") from continuing operations, adjusted income from continuing operations (non-GAAP), adjusted diluted EPS from continuing operations (non-GAAP) and core and non-core adjusted diluted EPS from continuing operations (non-GAAP)” respectively, reports operating income, operating margin, income from continuing operations and diluted earnings per share from continuing operations without the impact of non-cash asset impairment charges, acquisition-related expenses, restructuring charges, the TRU bankruptcy charge, tax reform, amortization of intangible assets, and non-cash share-based compensation for the periods presented, as applicable. These measures may be considered non-GAAP financial information as set forth in SEC Regulation G, Rule 100. The tables reconcile these measures to their corresponding GAAP-based measures presented in our condensed consolidated statements of income. We believe that adjusted operating income, adjusted operating margin, adjusted income from continuing operations, and adjusted diluted EPS from continuing operations provide useful information to management and investors regarding financial and business trends relating to our financial condition and results of operations. We believe that these non-GAAP financial measures, in combination with our financial results calculated in accordance with GAAP, provide investors with additional perspective regarding the impact of such charges on applicable income, margin and earnings per share measures. We also believe that these non-GAAP measures facilitate a more direct comparison of our performance to our competitors. We further believe that including the excluded charges would not accurately reflect the underlying performance of our continuing operations for the period in which the charges are incurred, even though such charges may be incurred and reflected in our GAAP financial results in the near future. The material limitation associated with the use of the non-GAAP financial measures is that the non-GAAP measures do not reflect the full economic impact of our activities. Our adjusted operating income, adjusted operating margin, adjusted income from continuing operations, adjusted diluted EPS from continuing operations and core and non-core adjusted diluted EPS from continuing operations are not prepared in accordance with GAAP, are not an alternative to GAAP financial information and may be calculated differently than non-GAAP financial information disclosed by other companies. Accordingly, undue reliance should not be placed on non-GAAP information.

The non-GAAP measures are discussed further and reconciled to their applicable GAAP based measures contained in this MD&A beginning on page 42.

In addition to the above non-GAAP financial measures, we also refer to a number of financial measures which are not defined under GAAP. We believe these measures provide management and investors with important information that is useful in understanding our business results and trends. The following represents our key financial measures:

Accounts receivable turnover: Twelve-month trailing net sales revenue divided by the average of the current and prior four fiscal quarters’ ending accounts receivable balances. This result is divided by 365 days to express turnover in terms of average days outstanding.

27





Core business sales: Net sales revenue associated with strategic businesses that we expect to be an ongoing part of our operations.
Current ratio: Current assets divided by current liabilities at the end of a reporting period, expressed as a ratio. 
EBITDA: Earnings before interest, taxes, depreciation and amortization expense.
Ending debt to ending equity ratio: Total interest bearing short- and long-term debt divided by shareholders’ equity at the end of a reporting period, expressed as a ratio.  
Gross profit margin: Gross profit divided by the related net sales revenue expressed as a percentage.
Inventory turnover: Trailing twelve month cost of goods sold divided by the average of the current and prior four fiscal quarters’ ending inventory balances to express turnover in terms of the number of times per year. 
Leadership Brand net sales: Net sales from brands which have number-one and number-two positions in their respective categories and include OXO, Honeywell, Braun, PUR, Hydro Flask, Vicks, Hot Tools, and Drybar.
Leverage ratio: Total current and long-term debt plus outstanding letters of credit, divided by EBITDA plus non-cash charges and the proforma effect of acquisitions, as defined in our Credit Agreement.
Non-Core business sales: Net sales revenue associated with business or assets (including assets held for sale) that we expect to divest within a year of its designation as Non-Core.
Online net sales: Net sales to pure-play online retailers, distinct online businesses of omni-channel customers and direct to consumers through Company-owned websites.
Operating margin: Operating income for the Company or a business segment divided by the related net sales revenue for the Company or a business segment. 
Organic business sales (previously referred to as Core business sales): Net sales revenue associated with product lines or brands after the first twelve months from the date the product line or brand was acquired, excluding the impact that foreign currency re-measurement had on reported net sales. 
Return on average equity: Trailing twelve month net income divided by the average of the current and prior four fiscal quarters’ ending shareholders’ equity. 
SG&A ratio: Total selling, general and administrative expense (SG&A) divided by net sales revenue.
Working capital: Current assets less current liabilities.


28


Overview
We are a leading global consumer products company offering creative products and solutions for our customers through a diversified portfolio of well-recognized and widely-trusted brands.  We have built leading market positions through new product innovation, product quality and competitive pricing.  We currently operate in three segments consisting of Housewares, Health & Home and Beauty.
In fiscal 2015, we launched a five-year transformational strategy designed to improve the performance of our business segments and strengthen our shared service capabilities.  This strategy has driven our decisions on where we will operate and how we will achieve our goals in markets around the world.  The overall design of our business and organizational plan is intended to create sustainable and profitable growth and improve organizational capability. 
Fiscal 2019 marked the completion of Phase I of our multi-year transformation strategy, which delivered performance across a wide range of measures. We improved organic sales growth by focusing on our Leadership Brands, made strategic acquisitions, became a more efficient operating company with strong global shared services, upgraded our organization and culture, improved inventory turns and return on invested capital, and returned capital to shareholders.

Fiscal 2020 began Phase II of our transformation and is designed to drive the next five years of progress. The long-term objectives of Phase II include improved organic sales growth, continued margin expansion, and strategic and effective capital deployment. We expect Phase II will include continued investment in our Leadership Brands, with a focus on growing them through consumer-centric innovation, expanding them more aggressively outside the United States, and adding new brands through acquisition. We anticipate building further shared service capability and operating efficiency, as well as attracting, retaining, unifying and training the best people.

In fiscal 2018, we announced a restructuring plan (referred to as “Project Refuel”) intended to enhance the performance primarily in the Beauty and former Nutritional Supplements segments. Project Refuel includes charges for a reduction-in-force and the elimination of certain contracts. During the first quarter of fiscal 2019, we expanded Project Refuel to include the realignment and streamlining of our supply chain structure. We are targeting total annualized profit improvements of approximately $9.0 to $11.0 million over the duration of the plan. During fiscal 2020, we incurred $3.3 million of pre-tax restructuring costs related to Project Refuel consisting of employee severance and termination benefits and contract termination costs. We estimate the plan to be completed during fiscal 2021 and expect to incur total restructuring charges of approximately $9.5 million. Restructuring provisions are determined based on estimates prepared at the time the restructuring actions are approved by management and are revised periodically. See Note 14 to the accompanying consolidated financial statements for additional information.
On January 23, 2020, we completed the acquisition of Drybar Products LLC ("Drybar Products"), for approximately $255.9 million in cash, subject to certain customary closing adjustments. Drybar is a fast-growing, innovative, trendsetting prestige hair care and styling brand in the multi-billion-dollar beauty industry. As part of the transaction, we granted a worldwide license to Drybar Holdings LLC, the owner and long-time operator of Drybar blowout salons, to use the Drybar trademark in their continued operation of Drybar salons. The salons will exclusively use, promote, and sell Drybar products globally.
During the fourth quarter of fiscal 2020, we committed to a plan to divest certain assets within our mass channel personal care business. The assets to be disposed of include intangible assets, inventory and fixed assets relating to our mass channel liquids, powder and aerosol products under brands such as Pert, Brut, Sure and Infusium. We expect the divestiture to occur within fiscal 2021. Accordingly, we have classified the identified assets of the disposal group as held for sale. The plan to divest these assets advances our strategy to focus our resources on our Leadership Brands.


29


Subsequent to the end of fiscal 2020, on March 13, 2020, we entered into an amendment to our Credit Agreement with Bank of America, N.A., as administrative agent, and other lenders (as amended, the "Credit Agreement"). The amendment extended the maturity of the commitment under the Credit Agreement from December 7, 2021 to March 13, 2025. Further, the amendment increased the unsecured revolving commitment from $1.0 billion to $1.25 billion. The amount of the accordion was increased from $200 million to $300 million. The accordion permits the Company to request to increase its borrowing capacity, not to exceed the $300 million commitment in the aggregate, provided certain conditions are met, including lender approval. Following the amendment, borrowings under the Credit Agreement bear interest at either the base rate or LIBOR, plus a margin based on the Net Leverage Ratio (as defined in the Credit Agreement) of 0% to 1.0% and 1.0% to 2.0%, respectively, for base rate and LIBOR borrowings. See Note 16 to the accompanying consolidated financial statements for additional information.
Significant Trends Impacting the Business

Potential Impact of COVID-19
On March 13, 2020, the President of the United States announced a National Emergency relating to COVID-19. There is a possibility of widespread infection in the U.S. and abroad, with the potential for catastrophic impact. As a result of these and other effects, we expect COVID-19 to adversely impact our business, which could be material. The impact includes the effect of temporary closures of, and limited hours of operation and materially lower store traffic at, customer stores. The COVID-19 pandemic is also impacting our third-party manufacturers, most of which are located in the Far East, principally China. The extent of the impact of COVID-19 on our business and financial results will depend largely on future developments, including the duration of the spread of the COVID-19 outbreak within the U.S. and globally, the impact on capital and financial markets and the related impact on consumer confidence and spending. These future developments are outside of our control, are highly uncertain and cannot be predicted. If the impact is prolonged, then it can further increase the difficulty of planning for operations. These and other potential impacts of the current public health crisis could therefore materially and adversely affect our business, financial condition, cash flows and results of operations.

Due to the impacts of COVID-19, we are experiencing favorable demand trends for some of our products, while others are being adversely impacted due to retail store closures and consumer uncertainty. At the end of fiscal 2020, we began to experience increased demand for certain products in our Health & Home segment, particularly thermometers. This trend continued into the beginning of fiscal 2021 and became more pronounced in other product categories such as humidification, water purification and air purification. Additionally, at the beginning of fiscal 2021, we began to experience favorable demand trends for OXO products within our Housewares segment as consumers engage in pantry stocking, cleaning, nesting and cooking at home. Our products that are more discretionary in nature or more dependent on the retail brick and mortar channel are experiencing unfavorable demand trends. All of our products are being adversely impacted by the effect of temporary closures of, and limited hours of operation and materially lower store traffic at, customer stores. We are also experiencing supply chain disruptions with some of our third-party manufacturers, which is adversely affecting our ability to meet consumer demand in product categories where it is strong. Accordingly, we expect that the net effect of COVID-19 will adversely impact our results for the first quarter of fiscal 2021, as well as the full fiscal 2021, and that impact could be material. This situation is changing rapidly, and additional impacts may arise that we are not currently aware of.


30


As part of a comprehensive approach to preserve our cash flow and adjust our cost structure to lower expected revenue, we have implemented a number of measures that will remain in place until there is greater certainty, a re-opening of retail brick and mortar stores and improved consumer demand. These measures include the following:

A graduated salary reduction for all associates, including named executive officers and the other members of the Company’s executive leadership team;
A reduction in the cash compensation of the Company's Board of Directors;
Suspension of merit increases, promotions and new associate hiring until further notice;
The furlough of associates in specific areas directly tied to sales volume, with assistance to maintain health insurance coverage, as well as a reduction of external temporary labor and reduced work hours;